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ABSTRACT 
Approximately 12 % of males in the Western world are likely to suffer at least one 
kidney stone in their life. The incidence of kidney stone disease in South Africa is 
similar in white males; however stone occurrence in the South African black 
population is extremely rare. The difference between the incidences of kidney stones 
in the black and white populations in South Africa is unexplained. In general, the 
role of several urinary proteins in the pathogenesis of this disease has been 
established. Bikunin is an example. The primary aim of this study was to isolate 
bikunin from the urine of healthy black and white male subjects and to investigate 
whether the protein from the black group is a more powerful inhibitor of CaOx 
crystallization than that from the stone prone white group. 
A wide range of crystallization experiments were used. These included C4C]-
oxalate deposition, CaOx crystal aggregation and nucleation as well as 
determination of Zeta potential and particle number-volume-size distribution. Four 
different forms of bikunin (commercial bikunin, protein precipitate containing bikunin, 
purified bikunin and deglycosylated bikunin) were studied. Bikunin was isolated and 
purified from the proteins precipitated from the urine of black and white subjects 
using immunoaffinity chromatography. Its purity was confirmed using sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE), Western blotting and 
matrix-assisted laser desorption/ionisation time-of-flight (MALO I-TOF MS). 
Commercial bikunin was deglycosylated using chondroitinase ABC and its inhibitory 
effect was studied in both synthetic urine and the urine obtained from black and 
white subjects in order to gain some insight into the role played by bikunin glycans in 
inhibiting calcium oxalate crystallisation. 
The crystallization experiments performed on the commercial bikunin provided 
convincing evidence that bikunin is an inhibitor of CaOx crystal growth and 
aggregation rather than nucleation. Further evidence on the possible role played by 
bikunin in retarding in vivo CaOx crystallization was provided by the experiments 
conducted on the protein precipitate containing bikunin. 
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These experiments demonstrated that the proteins precipitated from the urine of the 
two race groups retard CaOx crystallization irrespective of the urine from which it 
was derived. Structural differences were observed in the bikunin purified from the 
urine of the two race groups using immunoaffinity chromatography. MALDI-TOF MS 
demonstrated that bikunin isolated from the white subjects had less coverage of the 
bikunin amino acid, while the coverage by bikunin isolated from black subjects was 
larger. The concentration for urinary bikunin was determined to be 0.46 mg/L in 
blacks and 0.32 mg/L in white subjects but this difference was not statistically 
significant. Crystallization experiments demonstrated that purified bikunin, 
irrespective of the race group from which it was derived, is a strong inhibitor of CaOx 
growth and aggregation and a weak inhibitor of CaOx crystal nucleation. 
Importantly, aggregation inhibition by bikunin from black subjects was superior. A 
study comparing the inhibitory activity of bikunin after the removal of the glycans 
provided convincing evidence that bikunin glycans are responsible for this protein's 
ability to retard CaOx crystallization. Differences in the morphology of the crystal 
precipitated from the urine of black and white subjects were also noted using SEM. A 
predominantly COM crystal morphology was observed in the urine of black subjects 
compared to mainly COD in the white subjects urine. 
The results of this PhD project have provided meaningful insights into the 
inhibitory role played by urinary bikunin in the pathogenesis of CaOx urolithiasis in 
general and have also provided evidence that this protein may be a key role player in 
protecting the South African black population against this disease. 
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ABBREVIATIONS AND SYMBOLS 
a 1-m a1-microglobulin 
Amps ammonium persulphate 
ANOVA analysis of variance 
BB bikunin isolated from urine of black subjects 
BP proteins isolated from urine of black subjects 
BPP protein preciQitate isolated from urine of black subjects 
BUF black subjects' ultrafiltered urine 
BSA bovine serum albumin 
CaOx calcium oxalate 
CB commercial bikunin 
COM calcium oxalate monohydrate crystals 
coo calcium oxalate dihydrate crystals 
COT calcium oxalate trihydrate crystals 
cpm counts per minute 
cs chondroitin sulphate 
DB deglycosylated bikunin 
GAG glycosaminoglycan 
H1 heavy chain 1 
H2 heavy chain 2 
HPLC high performance liquid chromatography 
lA inhibition of C!99_r~ation 
In inhibition of nucleation 
lgG immunoglobulin 
kDa kilo dalton 
MALDI-TOF Matrix-assisted laser desorption/ionisation time-of-flig_ht 
MS mass spectrometry 
MSL metastable limit 
Na20x sodium oxalate 
PMSF phenylmethylsulphonylfluoride 
RS relative supersaturation 
SE standard error 
SEM scanning electron microscope 
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
WB bikunin isolated from urine of white subjects 
WP proteins isolated from urine of white subjects 
WPP protein preciQitate isolated from urine of white subjects 
WUF white subjects' ultrafiltered urine 
TEMED N,N,N'N'-tetramethylett}ylendiamine 
Tris Tris (hydroxylmethyl)meth_ylamine 
XRD x-ray powder diffraction 
Zp zeta potential 
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Chapter 1 
Introduction 
1.1 General 
Kidney stones, renal stones, and renal calculi are terms used to refer to the condition in 
which crystallized substances in the urine combine to form hard, solid and non-metallic 
concretions. These substances originate as microscopic particles and develop into a 
stone which can be located anywhere in the urinary tract (Figure 1.1) where they cause 
irritation and secondary infection. The medical term for this condition is urolithiasis. 
Figure 1.1 Urinary stones can be found anywhere in the urinary tract 
(http://www. ocurology. com/stones. html) 
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The disease was reported by Sir Grafton Elliot Smith in 1923 when stones were found in 
the pelvic bone of an Egyptian mummy from a 4400 BC tomb in Egypt (Clarke 1968). 
The formation of kidney stones is a relatively common condition that develops in 
12 % of men and 5 % of women in industrialized countries (Blacklock 1982). It is evident 
from the literature that urolithiasis is a multi-factorial disease dependent on a wide range 
of epidemiological variables such as climate, geography, race, occupation, diet, drinking 
water as well as clinical conditions (these will be discussed later). When waste material 
in the urine does not dissolve completely, crystals are likely to form. Small stones can 
pass out of the body on their own, although this can be painful. Large stones may 
require surgery, or they may be broken into smaller pieces with sound waves in a 
procedure called ultrasonic lithotripsy. The chemical composition of stones depends on 
the chemical imbalance in the urine. The discovery of an organic component in kidney 
stones dates back to 1684 (Butt 1956). 
There are four general categories of urinary stones according to their chemical 
composition (Elliot 1973; Gillet at. 1984; Ito eta/. 1992; Coe eta/ 2005). 
Calcium stones: Approximately 85 % of stones are composed predominately of 
calcium compounds (Elliot 1973; Gill et a/. 1984; Ito et a/. 1992). Calcium and oxalate 
are the most components of urinary calculi. Stones of this type are caused by an 
imbalance of these components in the urine. Another common stone type is calcium 
phosphate (Elliot 1973; Gill et a/. 1984; Ito at a/. 1992). The most common urinary risk 
factors for calcium stone production are hypercalciuria (excess calcium in the urine) 
(Broadus et a/. 1984, Brutus et a/. 1994), low level of citrate (Rudman et a/ 1982 
Hosting et a/ 1985; Cupisti et a/ 1992), high levels of oxalate (Merhoff 2001 ) and uric 
acid (Robertson et a/ 1978). The work described in this thesis focuses on calcium 
oxalate (CaOx) urolithiasis. 
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Magnesium ammonium phosphate stones (struvite): Struvite stones are also called 
infection stones because they form due to the presence of long standing urinary 
infection with certain bacteria that are able to split the urea into ammonium. This then 
allows ammonium to complex with magnesium and phosphate in the urine to form 
crystals and stones (Coe et at. 2005). These stones represent only 2.8 % of urinary 
calculi (Ramello eta/. 2000; Coe eta/. 2005). 
Uric acid stones: This type of stone occurs when the acid level in the urine is high as 
a result of dehydration and low urinary pH (Ramello et at 2000· Coe et a/ 2005). 
Approximately 9-10% of patients with kidney stone disease develop this type of stone 
(Ramello eta/. 2000; Coe eta/. 2005). 
Cystine stones: These stones are caused by an inherited kidney disorder that involves 
the excretion of amino acid of which cystine is a member. These stones represent only 
a small percentage (1-2%) of urinary calculi (Ramello et at. 2000; Coe et at 2005). 
1.2 EPIDEMIOLOGICAL FACTORS 
Various epidemiological factors have been reported to affect the risk of kidney stone 
formation. These include climate and geography, ethnicity, age, gender profession and 
diet. Each of these is discussed briefly below. The probability of forming stones varies 
in different parts of the world, the highest risk being reported in Saudi Arabia (20 %) 
(Robertson and Hughes 1994). The risk has been reported to be lower in Asia (1-5 %) 
than in Europe (5-9 %), North America (5-9 %), Canada (12 %) and the USA 13 % 
(Ramello eta/. 2000). Urinary stone occurrence is higher in countries with warm or hot 
climates. It is likely that stone formation under these circumstances is provoked by 
dehydration with resultant reduction of urine flow rate and increase in the concentration 
of solutes in the urine (Blacklock 1982). 
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Ethnicity may be an important epidemiological factor in urolithiasis as there are reports 
that it occurs more frequently in whites than blacks, irrespective of the geographic area 
concerned (Ramello et a/. 2000). For example, it has been reported that kidney stone 
disease in the USA is more prevalent in whites than in blacks (Finlayson 1978; Soucie 
et at. 1994). Several other groups have also been reported to show stone rarity, namely 
the Indians of Mexico, Peru, Ecuador and Bolivia (Finlayson 1978), Eskimos and 
Australia's aboriginal population (Scott 1977). In South Africa, stones occur in 10-15% 
of the white population but it is extremely rare (<1 %) in the black race group (Modlin 
1968). Indeed, it is this latter phenomenon that forms the primary motivation for 
undertaking the research described in this thesis. 
Stone formation is influenced by gender and age. Stones are more frequent in 
men than in women (i.e. male-to-female ratio is 4:1 ), although in children, the boy-to-girl 
ratio is 3:2 (Scott et a/ 1977· Hesse et a/ 1986). Peak presentation for adults is middle 
age. Children can present with stones at any age (e.g. premature, newborn to 
teenager) (LJunghall et at 1977). 
1.3 DIETARY FACTORS 
Diet is believed to be an important contributory factor in the aetiology of urolithiasis 
since several components of a normal diet can be lithogenic (Andersen 1973; 
Robertson et a/. 1987, 2000, Trinchieri et a/. 1991 ; Curhan et a/. 1993; Hesse et a/. 
1993; Massey et a/. 1993; Goldfarb et a/. 1994 ). Fluid therapy is a front-line approach 
for all stone formers because it is safe, cheap, and effective. A low fluid intake leads to 
concentrated urine and increases the risk of stone formation. Therefore increasing 
water intake to dilute urine and increase frequency of urination is an important part of 
treatment of the disease (Robertson et at. 1987; Ryall et at. 1989; McCormack et a/. 
1991 ; Borghi eta/. 1996; Parivar eta/. 1996; Rodgers 1997). 
Other dietary interventions can reduce the risk of stone formation . Restricting 
sodium and animal-protein consumption produces changes in the urinary environment 
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that should benefit the majority of stone formers, including a decrease in calcium and 
increase in citrate excretion (Blacklock 1982, Robertson and Peacock 1983). In the 
past, calcium oxalate stone patients were advised to restrict their intake of dietary 
calcium, as there was a belief that a high calcium intake increased the risk of stone 
formation (Curhan et a/. 1993, 1997). However, indiscriminant calcium restriction 
should be avoided, because it restricts the gastrointestinal binding of oxalate, leading to 
its increased absorption (Curhan et a/. 1993, 1997). Indeed, higher dietary intake of 
calcium may actually decrease the risk due to increased binding of calcium to oxalate in 
the gastro-intestinal tract, leading to a decrease in urinary oxalate excretion (Curhan et 
a/. 1993, 1997). On the other hand, a high oxalate intake may contribute to calcium 
oxalate stone production. Oxalate restriction should be considered for calcium oxalate 
stone formers, especially those with hyperoxaluria (Coe eta/. 2005; Garse et at. 2000) . 
Bran is a rich source of insoluble fiber that has been reported to reduce the 
absorption of calcium, which in turn causes a decrease in urinary calcium when 
included in the diet (Shah 1980; Ebisuno et a/. 1986). Oats, wheat bran and rice-bran 
are a good source of fiber foods that have been reported to have an effect in the kidney 
stone formation (Ebisuno et a/. 1986). They all contain phytate. This dietary agent has 
been found to be important in decreasing the rate of urolothiasis (Grases and March 
1989; Conte et a/ 1999 Grases et a/. 1999). Phytates (IP6) are salts of phytic acid 
formed with calcium, magnesium, iron, zinc and copper (Conte eta/ 1999: Garses and 
Llobera 1999). Phytate, a substance present in blood, urine, interstitial and intracellular 
fluids has been reported to inhibit crystallization of calcium salts (oxalate and 
phosphate) by reducing the level of calcium in the urine and therefore reducing the risk 
of forming kidney stones (Grases and March 1989; Conte et at. 1999; Grases 2000). It 
is a powerful agent for preventing calcifications in biological fluids and has been used in 
urolithiasis treatment (Grases and Costa-Bauza 1999). Moreover, it has been reported 
that phytate is significantly lower in stone formers (0.5 mg/L) than in healthy individuals 
(2.5 mg/L) (March eta/. 1998; Grasse eta/. 1999). 
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On the other hand, carbohydrates have been reported to increase urinary oxalate (Li et 
a/. 1986; Nguyen et a/. 1989, 1994; Reddy et a/. 2002) and urinary calcium (Lemann et 
a/. 1969; Thorn et a/. 1981 ; Rote et a/. 1986; Nguyen et a/. 1995), such that some 
clinicians have recommended that stone patients must avoid sugary products (Gaby 
1996; Piesse 1985; Nguyen eta/. 1986; 1994). 
1.4 PHYSICO-CHEMICAL FACTORS 
1.4.1 Mechanism of stone formation 
Kidney stone formation is a process that involves nucleation, growth and aggregation of 
crystals and their retention within the kidney (Gill 1984, Hess and Kok 1996). It is the 
end result of several physicochemical processes that commence with nucleation of 
crystals from a supersaturated solution. Many hypotheses have been advanced to 
account for these processes (Howard and Thomas 1958, Lonsdale 1968; Robertson 
and Nordm 1982; Kok and Khan 1994; Hess and Kok 1996; Ryall 1989; Hess et a/. 
2001· Coe eta/. 2005). 
Supersaturation 
Supersaturation is a prerequisite for the occurrence of crystallization in urine (Finlayson 
et a/. 1978). The level of saturation of the urine with respect to each of the stone-
forming compounds in urine determines whether crystals will form and whether they will 
aggregate or grow. Supersaturation permits the formation of crystals that can be 
retained in the nephron and form the nidus of a stone (Kavanagh and Rao 1994). The 
continual passage of the urine excessively supersaturated with one of the stone-forming 
salts may lead to spontaneous precipitation of that salt independently of inhibitors of 
crystallization. Urine is predominantly supersaturated with calcium oxalate monohydrate 
(COM) and dihydrate (COD) (Hess and Kok 1996). However, the occurrence of the 
trihydrate (COT) in urine and stones is rare (Hess and Kok 1996). 
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Crystal nucleation 
The initial phase transformation that leads to the formation of urinary stones is called 
crystal nucleation (Finlayson et at. 1978; Finlayson et a/. 1984). This process begins 
with the clustering of stone salts in solution into loose conglomerates which can grow 
due to the decrease in free energy that is associated with the change from liquid to solid 
phase (Finlayson et a/. 1978; Finlayson et a/ 1984 Hess and Kok 1996). The crystal 
nucleation step requires urine to be supersaturated with respect to crystallizing salts 
such as CaOx. For all solutions (including urine) there are three zone of relative 
supersaturation (RS) as demonstrated in Figure 1.2. (Hess and Kok 1996). The latter 
provides a summary of three scenarios that might be a driving force in the crystallization 
of salts. Briefly, scenario 1 describes the formation of crystals in a solution without any 
crystals. In this case relative supersaturation is increased by addition of Ca2+ and ox2+ 
until RS reaches values in the range of 80-100. The solution will then become unstable 
as it passes the metastable limit (formation product) and the crystals will start to form 
spontaneously. This process is termed homogeneous nucleation (Finlayson 1978; 
Nordm eta/ 1993, Hess and Kok 1996). 
Scenario 2 describes a solution containing CaOx crystals and the metastable 
limit is lower. The presence of CaOx crystals increases the concentration of ions 
beyond the supersaturation value. Thus the RS of a solution is continuously increased 
and the formation product is exceeded culminating in spontaneous nucleation. This 
process is called secondary nucleation. Heterogeneous/secondary nucleation in 
scenario 3 is a process that is unlikely to occur in the urine due to the presence of many 
foreign contaminants, such as crystals and macromolecules which may serve as nuclei 
and cause heterogeneous nucleation. Epitaxy is an extension of the theory of 
heterogeneous nucleation (Lonsdale 1968; Thorne et a/. 1983; Mandel et at. 1991 ). In 
this process, the material of one crystal precipitates onto another crystal and the lattice 
dimension of the two matches and induces the crystallization in urine. 
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Figure 1.2: Relative supersaturation and CaOx crystal nucleation. A: Aqueous 
solution of calcium and oxalate. 8: Aqueous solution of calcium oxalate crystals. 
C: Whole urine containing foreign surfaces and crystals (Hess and Kok 1996). 
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Crystal growth 
The addition of new crystal components onto a crystal nucleus is called crystal growth. 
Crystal growth occurs mainly due to the net difference between the energy needed for 
the formation of new crystalline components in solution and the crystal lattice itself 
(Hess and Kok 1996). The incorporation of new crystals components into a crystal 
lattice is a complicated mechanism (Hess and Kok 1996). Crystal growth occurs due to 
processes called speciation, bulk diffusion and adsorption. Speciation refers to the 
binding of monomers to form complexes and these monomers migrate through the 
solution by a process called bulk diffusion. Bulk diffusion refers to the process in which 
the newly formed crystals travel through the solution and attach to the crystal by 
adsorption (Hess and Kok, 1996). 
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Supersaturation is usually approximated for undissolved salts by the ratio of their 
concentration in the urine to their solubilities and calculated by computer algorithms 
using eq.1 below (Gill 1984, Coe et at. 2005). 
Equation 1 -dS!dt = dP!dt = ~Sfl 
where S= supersaturation; t= time; P= precipitate; tt; = reaction rate constant; A= surface 
area for crystallization ; 11 =order of the reaction. 
At supersaturation values less than 1, crystals of a substance will dissolve and crystal 
can form and grow at values greater than 1. 
Crystal aggregation 
The term aggregation refers to the process whereby crystals combine to form a large 
particle under all states of saturation (Hess and Kok 1996). Primary aggregation of 
particles is a result of malgrowth of crystals resulting in the formation of a polycrystalline 
particle that expands wide mutually without any predominant orientation from the 
surface of other crystals (Sohnel and Grases 1995). Secondary aggregation proceeds 
by collision of particles suspended in the liquid induced by shear forces acting in the 
liquid (Sohnel and Grases 1995). 
Compared to nucleation and growth, crystal aggregation is more important in the 
process of stone formation because calcium oxalate growth is too slow to produce 
clinically significant particles within the transit time in the urinary tract, whereas 
aggregation occurs within seconds and is thus more dangerous for the formation of 
large crystalline particles in renal tubules (Kok et at. 1988; Hess and Kok 1996). 
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1.5 INHIBITORS 
Inhibitors are chemical substances which occur naturally in urine and which retard or 
prevent the crystallization of salts. They have been a consistent theme of urinary stone 
research and fall into two classes depending on their molecular weight, namely 
"micromolecules", such as citrate, pyrophosphate and magnesium, and 
"macromolecules", which include proteins and glycosaminoglycans. Each of these will 
be discussed briefly below. 
1.5.1 MICROMOLECULES 
Several small molecules, such as citrate; pyrophosphate and magnesium have been 
identified to as inhibitors of urinary crystallization salts (Pak 1987; Ryall et a!. 1988; Pak 
1991; 1994; Ryall1997; Khan and Kok 2004) . 
Citrate: Citrate has been associated with calcium stone disease since 1934 (Hastings 
et a!. 1934; Ryall 1997). A number of studies have demonstrated that citrate has an 
inhibitory effect on crystal growth (Welshman eta!. 1972; Meyer eta!. 1975), nucleation 
(Doremus et a/ 1978; Hallson et a! 1983; Schwille et a! 1999) and aggregation (Ryall 
et a!. 1981 ; Kok et a!. 1988) in urine. It is also known to bind to the CaOx crystal 
surface (Ryall et a!. 1981 , Kok et a!. 1988) thereby influencing both crystal growth and 
aggregation. As a result it is regarded as a chelator of calcium ions, which efficiently 
lowers supersaturation, the driving force for crystallization. Citrate reduces 
supersaturation by binding to calcium (Khan and Kok 2004). A decrease in citrate 
excretion (hypocitraturia) has been reported in the urine of stone formers, thereby 
providing convincing evidence in support of it being a critical risk factor in kidney stone 
disease (Hodgkinson 1962; Rudman eta/. 1982; Menon and Mahle 1983; N1car 1983; 
Hoskmg eta/ 1985; Pak 1987; Cupisti eta! 1992; Pak 1994 Ryall 1997; Khan and Kok 
2004). The role of citrate in urolithiasis in the clinical treatment has been extensively 
studied by Pak (Pak 1987; Pak 1991; Pak 1994) and supplementation has become an 
accepted for stone therapy (Ryall 1997). Amongst these supplements are potassium 
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citrate (Schwille eta/. 1987; Berg eta/. 1990; Ogawa 1994), calcium citrate (Levine et 
a/. 1994; Sakhaee et a/. 1994), calcium-sodium citrate (Schwille et a/. 1997) and 
potassium-magnesium citrate (Ettinger et a/. 1997). In a recent study evidence was 
provided that the use of sodium citrate, in the form of CitroSoda, favourably altered 
many risk factors of calcium oxalate urolithiasis and proved to be an effective 
preparation for the prophylactic and therapeutic management of calcium oxalate 
urolithiasis (AIIie-Hamdulay and Rodgers 2005). 
Pyrophosphate: Pyrophosphate was the first inhibitory component of urine to be 
isolated and identified (Fieish and Bisaz 1962; Ryall 1997). It is present in the urine at 
concentrations of 15-100 !JM (Khan et a/. 2004) and has been found to inhibit COM 
crystal growth by 50 % at 16-20 IJM (Ryall eta/. 1988). It has also been reported to 
inhibit CaOx crystal nucleation (Doremus et a/. 1978), growth (Meyer et a/. 1975, 
Welshman et a/. 1972) and crystal aggregation (Ryall et a/. 1981 ) in inorganic solutions. 
Pyrophosphate excretion has been reported to be significantly reduced in stone formers 
as compared with healthy individuals (Conte et a/. 1989). The excretion of 
pyrophosphate can be increased by oral orthophosphate therapy (Russel et a/. 1976), 
potassium phosphate (Breslau eta/. 1995) and diclofenan sodium (Sharma eta/. 1992); 
however therapy has not proven effective in preventing stone formation (Khan and Kok 
2004). 
Magnesium: Magnesium has long been associated with kidney stone disease. It has 
been reported that it can reduce the crystallization of CaOx by complexing with the 
oxalate to form soluble magnesium oxalate, thus reducing the amount of oxalate ions in 
the urine (Desmars and Dermas 1973, Ryall 1997). Although magnesium has been 
reported to inhibit CaOx nucleation (Doremus et a/. 1978), growth (Li et a/. 1985) and 
aggregation (Ryall eta/. 1981 ), other studies have also reported that it has no effect on 
nucleation (Li et a/. 1985), growth (Meyer and Smith 1975; Welshman et a/. 1972) and 
aggregation (Robertson and Peackock 1972). A similar confusing array has also been 
seen on reports on the levels of urinary magnesium in stone formers and healthy 
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subjects (Ryall 1997). In one study, urinary magnesium in stone formers was found to 
be equal to or higher than healthy individuals (Joh ns::;orr et at. r9QO), whereas in other 
study it was found to be lower in stone formers (T inchreri et at 1 o ). Other conflicting 
results have been reported in the literature regarding the use of magnesium 
supplementation in the treatment of urolithiasis. For example, it was found in one study 
that magnesium unfavourably increased urinary calcium excretion and urinary pH 
(Fetner et a/. 1978). On the other hand other studies have reported prophlytic effects 
(Moore and Brunce 1964; Johansson et a/. 1980; Parivar et a!. 1996) and found a 
significant decrease in oxalate excretion after magnesium supplementation 
(Zimmerman et at. 2003). 
1.5.2 MACROMOLECULES 
Of the two classes of inhibitors described, macromolecules are the most widely 
investigated today. In the context of urolithiasis, "macromolecules" refer to urinary 
glycosaminoglycans and proteins. Numerous studies have shown that normal urine 
contains macromolecular substances that are capable of preventing and reducing CaOx 
crystal formation and aggregation (Boyce 19o8 Morse and Resnick et a!. 1989; Jones 
and Resnick 1990; Ryall eta!. 2000; Khan and Kok 2004). 
G/ycosaminoglycans (GAGs) 
GAGs (chondroitin sulphate (ChS), dermatan sulphate, hyaluronic acid (HA), 
heparin/heparan sulphate and keratin) are polysaccharides, composed of repeating 
disaccharide units (Roberts and Resnick 1986). ChS is the most abundant urine GAG 
( berts and Resn1c" 1986). The organic matrix of the stone accounts for 2-3 % of the 
total dry weight and heparan sulphate (HS) and HA have been the only GAGs that have 
been shown to be present in both the matrix of stones, and the CaOx crystals formed in 
the urine (Roberts a a Res ck 986 Ryall eta/. 1997; Khan et. a/. 2004). GAGs have 
a varying molecular weight of 18 - 40 kDa and account for 20 % of the matrix of kidney 
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stones. In vitro studies have demonstrated that they inhibit growth and aggregation of 
calcium oxalate crystals (Roberts and Resnick 1986; Ryall et a/. 1997; Khan and Kok 
2004). Studies have shown that HS, HA and ChS affects the precipitation of CaOx 
(Khan and Kok 2004). ChS has been reported to inhibit crystal growth, aggregation, 
nucleation mass deposition and agglomeration (Shum et a/. 1999; Erturk et a/. 2002; 
Schepers et a/. 2002). On the other hand GAGs have been reported to promote 
nucleation (Robertson et a/. 1989) and growth rate (Kohri et a/.1989). GAGs contain 
post-translation modifications such as phosphorylation or glycosylation, and these may 
be important for their inhibitory activity. There are no significant urinary excretion 
differences of between stone formers and healthy subjects (Harangi eta/. 1996). 
Urinary Proteins 
The organic matrix of kidney stones constitutes 2.5 % of dry weight containing lipids, 
carbohydrates and proteins. The latter comprise 64% of the stone matrix itself (Boyce 
and Garvey 1956). Albumin , a and y-globulin and Tamm-Horsfall Protein (THP) were 
the first proteins to be identified in the stone matrix (Boyce et a/. 1968). Several 
proteins have been identified as having a role in the inhibition and promotion of CaOx 
crystallization. These include nephrocalcin (Nakagawa et a/. 1983; Coe et a/. 1991 ); 
uropontin (osteopontin) (Worcester 1992; Worcester eta/. 1995; Worcester eta/. 1996; 
Khan et a/. 2004); THP (Grant et a/. 1973; Rose et a/. 1982; Hess 1992; Hess et a/. 
1993); Albumin (Boyce 1968; Atmani et a/. 1998; Ryall eta/. 1991 ; Grover eta/. 1998); 
urinary prothrombin fragment 1 (UPTF1) (Doyle et a/. 1991 ; Grover et a/. 1999; 
Durrbaum eta/. 2001 ; Webber eta/. 2002 ; Webber eta/. 2003); inter-a-(trypsin) inhibitor 
(Sorenson et a/. 1990; Atmani et a/. 1993; Dawson et a/. 1998; Moriyama et a/. 2001 ) 
and bikunin (Shulman 1955; Balduyck et a/. 1982; Sugiki et a/. 1989; Fries et a/. 2000; 
Medetognon-Bonissan eta/. 1999; Yang eta/. 2005). Bikunin and inter-a-(trypsin) (1-a-
1) inhibitor will be discussed in detail later. 
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Nephrocalcin (NC): This is a glycoprotein with a molecular weight of -14 kDa. It has 
been reported to self-aggregate into larger molecules that range from 23-68 kDa 
(Worcester et a!. 1987; Nakagawa et a/. 1990). NC is composed of 110 amino acid 
residues of which 25 % are glutamic and aspartic acid (Khan eta/. 2004). It has been 
reported that it contains 2 cystein and 2 or 3 y-carboxyglutamic acid residues which play 
a significant part in its ability to inhibit CaOx aggregation (Hess et a/. 1989; Coe et a/. 
1991 Nakagawa eta/. 1991 ), nucleation and growth (Hess et a/. 1989; Coe et a/ 1991; 
Khan and Kok 2004). Besides inhibition of the physical processes of crystal formation 
and aggregation, NC is also able to prevent attachment of crystals to the surface of 
renal epithelial cells. NC isolated from the urine of stone formers has been found to be 
structurally abnormal and to lack Gla residues (Nakagawa et a/. 1983). The identity of 
NC remains to be authenticated because its amino acid sequence has not been 
described (Khan eta/. 2004). 
Uropontin (Osteopontin): Urinary UPN was originally isolated as a glycoprotein with a 
molecular weight of 50 kDa (Khan et a/. 2004) and has a high asparagine content 
accounting for 16-20% of the amino acids. UPN is a member of the aspartic acid-rich 
protein super family, a family characterised by a structure containing the Arg-Giy-Asp 
(RGD) sequence (Kohri et a/. 1990; Konya et a/ 2003). It is found in urine, human 
CaOx stones and CaOx and calcium phosphate (CaP) crystals grown in human urine 
(EI1ot and Rabmow1ts 1980; Wesson et al 1998; Worcester 1996). UPN was originally 
isolated from mineral bone matrix and thereafter isolated from both human urine and 
primary cultures of mouse kidney cortical cells, by virtue of its ability to inhibit calcium 
oxalate crystal growth (Butler 1989; Malyankar eta/ 1997). 
UPN can modulate calcium oxalate crystallization by inhibiting crystal nucleation, 
growth and aggregation (Elliot and Rabinowits 1980; Sh1gara et a/. 1992; Hoyer 1994; 
Lieske eta/. 1995; Asplin eta/. 1997; Wesson eta! 1998; Worcester 1996). Like NC, 
UPN can inhibit binding of COM to BSC-1 cells (Wesson eta/ 1998). It has not been 
tested for an effect on crystal endocytosis, its RGD peptides are able to block crystal 
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uptake by these cells in vitro (Konya eta! 2003). Stone formers have been reported to 
excrete less UPN than non-stone formers, presumably because of the incorporation of it 
in crystal of the growing stone (Khan and Kok 2004) 
Tamm-Horsfall protein (THP): THP is the most abundant protein in human urine with a 
molecular weight of 80 -100 kDa (Tamm and Horsfall 1950; Ryall 1997). It is produced 
in the kidney and specially localized in the epithelial cells of the loop of Henle. THP, 
also called uromucoid is another urinary glycoprotein, which has long been believed to 
play a role in stone formation (Grant eta!. 1973; Hess 1992). 
Although THP has been the most intensely studied protein associated with 
urolithiasis, varying results from different studies have been controversial and thus its 
exact contribution to urolithiasis remains unclear (Khan and Kok 2004). Some studies 
report that THP inhibits and promotes CaOx crystallization depending on the 
experimental conditions (Grover eta!. 1998; Hess 1994) while others have reported that 
THP can inhibit CaOx and CaP crystallization (Rose et a!. 1982). Several reports have 
indicated that THP inhibits nucleation and growth and aggregation (Finlyason 1978; 
Hess eta!. 1991 ; Hess eta!. 1993). Other studies have reported that THP has no effect 
on nucleation and a minor effect on crystal growth (Yoshioka et a!. 1989; Hess 1992; 
1994). There appears to be no differences in THP excretion of healthy subjects 
compared to stone formers (Grant 1973; Bichler eta! 1976; Erwin et al 1994) however 
structural differences have been reported in THP isolated from healthy individuals and 
stone formers. It was demonstrated that THP isolated from the urine of stone formers 
contained less carbohydrates (mainly sialic acid) than the THP obtained from healthy 
subjects (Hess eta!. 1991 ; Hess eta!. 1995). 
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Albumin: After THP, albumin is the most abundant protein in the urine (Hess et at. 
1989; Grover et at 1998). This protein is manufactured in the liver and has been 
detected as the major component in the matrix of all urinary stones (Boyce 1968) as 
well as in urinary crystals (Atmani et at. 1998). Albumin has a molecular weight of 66 
kDa. The effect of albumin on CaOx crystallization has been extensively studied both in 
inorganic solution and whole urine (Hess 1989; Edyvane 1987; Ryall et al. 1991 ; 
Mensah 2004). It has been reported to have a strong affinity for COM crystals but does 
not inhibit its growth (Edyvane et at 1987; Ryall et at. 1991 ). It has also been shown 
that albumin inhibits CaOx crystal aggregation in a concentration dependant manner 
(Ryall et at. 1991 ; Worcester 1996; Grover et at. 1998) and promotes CaOx nucleation 
(Grover et at 1994; Khan et at. 2004). Albumin has the ability to bind other urinary 
proteins and it exists either in monomeric or polymeric form when dissolved in solution. 
Prothrombin Fragment 1 (UPTF1 ): Before being called UPTF1 this protein was 
originally referred to as crystal matrix protein (CMP) because of its selective inclusion 
into CaOx crystals (Doyle et at. 1991 ). The amino acid sequence analysis showed an 
identity to prothrombin and was therefore called UPTF1. UPTF1 is a protein with a 
molecular weight of 31 kDa. This protein is found in calcium stones and is also located 
in greater quantities in the human kidney of the stone formers than in the healthy 
controls (Doyle et at. 1991 · 1995). 
UPTF1 was found to be a potent inhibitor of CaOx growth and aggregation in 
ultrafilted urine (Ryall et at 1995; Doyle et at. 1991 ). In this experiment UPTF1 
decreased crystal aggregation and the amount of CaOx deposition at 1.25 -10mg/L 
concentrations. UPTF1 was also demonstrated to inhibit crystal growth and 
aggregation by 25 % at a concentration of 1.25 mg/L. In an experiment comparing 
inhibitory activity of different proteins, UPTF1 was found to be a better aggregation 
inhibitor than THP, prothrombin, a-1m or albumin and it was the only protein that 
reduced crystal growth (Grover et at. 1999). Studies on UPTF1 isolated from the urine 
of black and white South African subjects will be described in Section 1.6 which follows. 
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1.6 CaOx UROLITHIASIS IN SOUTH AFRICA 
As stated earlier, the occurrence of kidney stones in the black South African population 
is extremely rare (Modlin 1968; Whalley et a/. 1998). However, kidney stones in the 
white population occur with no less frequency than in other Western communities. The 
first recorded case of a kidney stone in a black South African was in 1927, when 
Vermooten reviewed the Johannesburg General Hospital records from 1922-1935 
(Vermooten 1937). One black patient was treated for renal calculi during that period 
compared to 273 white patients. Urinary tract CaOx stones have been reported to be 
the most common stone type found in black South Africans on those rare occasions 
when such a condition arises (Beukes eta/. 1987). 
In an attempt to identify factors which may play a role in the exceptionally rare 
incidence of stone formation in the black population, studies involving urine chemistry, 
diet, solute handling and the presence and absence of promoters and inhibitors in this 
e nic group have been undertaken in the Kidney Stone Research Laboratory at the 
University of Cape Town during the past several years (Craig et a/ 2000, 2001; 
Durrbaum et a/. 2001; Lewandowski et a/. 2001; Rodgers and Lewandowski 2002; 
Webber et a/. 2002; Webber et a/. 2003; Lewandowski and Rodgers 2004 (a); 
Lewandowski and Rodgers 2004 (b); Webber eta/. 2005; Rodgers 2006). 
Differences in comparing the 24 hr urinary composition in normal black and white 
male subjects have been reported by other workers. These have shown that blacks 
have higher urinary volumes, osmolality, ionized calcium and sodium levels, while their 
total calcium, phosphate and citric acid levels and urinary pH are lower than the white 
population (Modlin 1968; Whalley eta/. 1998). Results from our own urine studies have 
confirmed that citrate is lower in black groups (Lewandowski et a/. 2001 ). This is 
counter-intuitive because urinary citrate is one of the most powerful natural inhibitors of 
CaOx crystal formation. Furthermore, this same study showed that urinary oxalate was 
higher in a small group of black subjects when compared to a matched group of white 
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subjects. Thus urine composition alone does not appear to adequately account for the 
rarity of stones amongst South Africa's black population. 
Other studies from our research group and others have indicated that dietary 
intake of calcium, oxalate and protein is significantly lower in black subjects (Vermooten 
1937; Wise et a/. 1961 ; Modlin 1968; Whalley et a/. 1998; Lewandowski et a/. 2001 ). 
Furthermore, in a study in which a combined low calcium-high oxalate diet was 
administered to black and white subjects, oxaluria increased significantly in the white 
group (as expected) but not in the black group (Lewandowski et a/. 2002). This 
observation prompted the authors to suggest that blacks possibly have a lower oxalate 
absorbance rate (Whalley et at. 1998; Lewandowski et at. 2002) and possibly a different 
renal handling mechanism with respect to calcium and oxalate (Lewandowski et a/. 
2002). 
Since routine urinary components cannot explain the rarity of stones in black 
South Africans, our research group has also undertaken an ongoing investigation of the 
role of urinary proteins in this context. Since urinary proteins have been shown to have 
inhibitory properties in other studies elsewhere in the world, it was decided to continue 
probing this area in the South African context. These included UPTF1 , THP and 
albumin. These studies have yielded interesting results . 
THP was isolated from the urine of black and white male subjects and various 
techniques including matrix-assisted laser desorption I ionization time of flight mass 
spectrometry (MALDI-TOF MS), amino acid analysis and tryptic finger printing digestion 
were used to characterize the protein (Craig et at 2000). Structural differences were 
also observed in the THP isolated from the two race groups. For example, THP from 
the black subjects had a higher molecular weight, more cystein and glycine, and less 
alanine, valine, leucine and phenylalanine (Craig et at 2004; Rodgers . 2006). The 
inhibitory effect of THP on CaOx crystallization was tested in various crystallization 
experiments. THP isolated from black subjects was demonstrated to be a more potent 
inhibitor of COM crystal aggregation than that from whites (Cra1g et at. 2001; Rodgers 
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2006). It was therefore concluded that the stone rarity in the black population might be 
linked to the more potent activity of this race group's THP in inhibiting aggregation 
(Cra1g et at. 2001 ). 
In another study, UPTF1 was isolated from the urine of black and white male 
subjects and characterized using N-terminal sequencing, amino acid analysis and 
MALDI-TOF MS ebber et at. 2002). Structural differences were observed in the 
proteins isolated from the two race groups. For example, the amino acid analysis 
conducted under basic conditions demonstrated a greater number of Gla residues in 
UPTF1 from black subjects (Webber et at. 2003). The inhibitory activity of UPTF1 was 
compared using various crystallization experiments. UPTF1 from both race groups was 
found to be a potent inhibitor of CaOx growth and aggregation in ultrafiltered urine 
(Webber et at. 2002, 2003). It was also demonstrated that UPTF1 isolated from black 
male subjects is a stronger inhibitor of CaOx crystal growth and aggregation in synthetic 
urine and ultrafiltered urine than that isolated from whites (Webber et at. 2002). 
Albumin is another protein that was selected for investigation on the basis of its 
reported inhibition on CaOx crystallization. Urinary albumin was isolated in order to 
study its role in the context of the urolithiasis anomaly amongst the South African 
population groups. Results from sedimentation and zeta-potential experiments 
demonstrated that albumin isolated from black male subjects inhibited crystal 
aggregation to a greater extent than that isolated from white subjects, and thereby 
confirmed its possible role in the protection of the black population (Mensah 2004; 
Rodgers et at. 2006) 
The above-mentioned studies on urinary proteins have encouraged us to 
continue probing this area in our effort to identify factors which might afford this 
population group unique protection against kidney stone formation . The protein 
selected for further study in the present project was bikunin. 
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1.7 BIKUNIN 
The set of plasma proteins comprising inter-a.-(trypsin) Inhibitor (la.l) and related 
molecules is collectively referred to as the la.l family (Shulman 1955; Balduyck et a/. 
1982; Sugiki et at. 1989; Fries et at. 2000; Medetognon-Bonissan eta/. 1999; Yang et 
at. 2005). The family is characterized by the unique covalent linkage between the 
heavy chains and the chondroitin sulphate chain of bikunin. Figure 1.3 is a schematic 
representation of la.l family. la.l proteins belong to the super-family of Kunitz-type 
protease inhibitors. la.l itself is a macromolecule with a molecular weight of 180 - 220 
kDa (Gerbhard et a/. 1990; Hochstrasser et a/. 1979; Kobayasha et a/. 1988; Atmani et 
a/. 1999; Dean et at. 2000; Medetognon-Benissan et at. 1999; Suzuki et a/. 2001 ). It is 
mainly synthesized in the liver and excreted in plasma and urine (Gerbhard et at. 1990). 
N 
I ter-a-t p ·in 
inhibitor (ITI) 
Pre-a-tryp ·in 
inhibitor (Pal) 
rinar tr psin 
inhibitor (Ull) 
Figure 1.3: la l family; HC- Heavy chain , CS- chondroitin sulphate chain (Picture taken 
from http://www.glycoforum.gr.jp/science/hyaluronan/HA22/HA22E.html) 
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It is comprised of three distinct polypeptide chains. Two heavy chains, H1 and H2, have 
molecular weights in the ranges of 65 -101 kDa and 70 -106 kDa, respectively 
(Medetognon-Benissan et a/. 1999; Dean et a/. 2000; Suzuki et a/. 2001 ). These are 
covalently linked via a chondroitin sulphate moiety to a light chain known as bikunin. 
The covalent chondroitin sulphate inter-link between these three peptides is termed a 
protein-glycosaminoglycan-protein cross link (Kobayasha eta!. 1988). 
The connection between lal and stone disease was established in 1909, when it 
was demonstrated that the proteolytic activity of trypsin was inhibited by urine (Gebhard 
and Hochstrasser 1986). The physiological role of lal remains unknown (Atmani et a/ 
2004). 
Bikunin is referred to by several other names in the literature, such as urinary 
trypsin inhibitor (UTI), ulistatin, urinastatin, acid- stable trypsin inhibitor (ASTI), uronic-
acid-rich protein (UAP) and Hl-30 (Shulman 1955; Sugiki et a/. 1989; Faarvagn et a!. 
1965; Gerbhard eta/. 1990; Fries and Blom 2000). Bikunin was first isolated in 1955 
(Shulman 1955) by researchers working on mucopolysaccharide, leukemia and 
urolithiasis, and it was originally referred to as UTI (Shulman 1955; Balduyck et a/. 
1982; Fries and Blom 2000). UTI was found to remain soluble and active after 
treatment with strong acids and was therefore also called ASTI (Sugiki eta/. 1989). 
The name UAP was given in view of its composition. It was later named Hl-30 
because of its molecular weight and after a polypeptide identical to UTI was released 
when it was digested with trypsin. Other names for bikunin such as mingin (Astrup and 
Nissen 1964 Faarvagn et a/. 1965), ulistatin, urinastatin have also been used 
(Gerbhard eta/. 1990; Fries and Blom 2000). In 1990, it was proposed that the name 
bikunin be adopted (Gerbhard eta/. 1990). This name is now commonly used to refer 
to this protein. Bikunin is a structure-based name since the amino acid sequencing has 
shown that the protein contains two proteinase inhibitor domains (Gerbhard eta/. 1990). 
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Bikunin is synthesized in the liver and originates from common mRNA that also codes 
for another protein, a1-microglobulin (a 1-m) (Atmam 2001· Fries and Blom 2000). After 
bikunin is synthesized, cleavage occurs in the Golgi apparatus of the cell and it is 
released and eliminated in urine or serum either in its free form or bound to the two 
heavy chains of lal (Fries and Blom 2000). Immunohistochemical staining using renal 
tissue samples and reverse transcriptase polymerase chain reaction experiments have 
demonstrated that bikunin is produced in the kidneys (Xu et a/ 1998). It is localized in 
the cells of the proximal tubular cells of normal human beings and it is highly 
glycosylated (Fries and Blom 2000; Medetognon-Bonissan et at. 1999; Yang et a/. 
2005). Bikunin is composed of a 15-16 kDa polypeptide chain, and -7-8 kDa 
chondroitin sulphate side chain and an N-linked oligosaccharide of about 1-2 kDa 
(Medetognon-Bonissan eta/. 1999; Yang et at. 2005). The bikunin glycans account for 
approximately one third of the molecular mass including the important chondroitin 
sulphate chain, which links bikunin to the heavy chains. In 1981, the bikunin 
carbohydrates were identified as : a) ~n 0 linked (GaiNAc-rich chain) attached to serine 
residue at position 10 of the core protein linked via the chondroitin sulphate that 
contains 15 disaccharide repeats; and b) an N-linked oligosaccharide at position 45 
(Hochstrasse et a/. 1981 ) Figure 1.4. The CS linkage to bikunin is a typical 0-xylosyl-
serine (Balduyck at at. 1986). 
22 
HC2 
R'~ ~ . 
I 
0 
• ~ 
• 1:1 
• <J 
<I 
• 
blkun 
ShwV8 
Chapter One 
I 
1 5 
•-a-•-o• .!:j ·~ 
Hll'lar~an 'I 
• <I <I 
I 
• 
',0 
• 
• 
Truncation 
Y'f' 
Figure 1.4: Bikunin glycosylation (Balduyck at 
a/. 1986). 
This light chain is responsible for the antitryptic activity of lal in the inhibition of various 
enzymes such as trypsin and chymotrypsin (Atmani eta/. 1996). Bikunin fragment is the 
N-terminal portion of lal responsible for the protease inhibitory activity (Morri et a/. 
1985). 
Varying molecular weights of bikunin isolated from urine have been reported: 70 
kDa (Boyce et at. 1956); 68 kDa (Prat et a/. 1989); 60-70 kDa by gel filtration 
(Muramatsu et at. 1980; Slota et a/. 1994); 45 kDa (Bourguignon et a/. 1989; Odum 
1990; Malki eta/. 1992; Route eta/. 1992); 40 kDa (Sorensen eta/. 1990; Kobayasha et 
a/. 1998); 35 kDa (Atmani eta/. 1993a; Tang eta/. 1995; Ebisuno eta/. 1999; Okuyama 
et a/. 2003); 30 kDa (Enghild et a/. 1989, Morikawa et a/. 1994); 29 kDa; 20-25 kDa 
(Mizon eta/. 2002); 17 and 24-28 kDa (Medetognon-Benissan eta/. 1999; Yang eta!. 
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2005). It has also been reported that bikunin degrades to lower molecular weights (14 
and 8 kDa) after isolation (Hochstrasser et at. 1979; Kobayasha et at. 1988; Atmani et 
a/. 1999). The many isomers appear to be a result of variations in the GAGs and 
polysaccharide side chains, and the amount of sulphation (Medetognon-Bonissan et at. 
1999; Yang eta/. 2005). 
Difficulties have been encountered in isolating bikunin, especially when using 
immunoaffinity chromatography since commercially available antibodies bind to both 
bikunin and the heavy chains of lal (Atmani et at. 1999). Trypsin-affinity 
chromatography has therefore been employed because bikunin binds trypsin and 
inhibits its activity (Atmani eta/. 1999). Other methods, like ion exchange-trypsin affinity 
chromatography have also been exploited (Medetognon-Benissan et at. 1999). Bikunin 
isolated from human urine has been reported to have concentrations ranging from 6.25 
nmoi/L to 500 nmoi/L in normal men and women (Dean eta/. 2000; Kobayashi et al. 
1998). However the 500 nmoi/L urinary bikunin concentration reported by Kobayashi et 
a/. (1998) has been seen as an overestimate, since it will translate to the equivalent of 
17.5 mg/day, which is unlikely considering that albumin, which is the second most 
abundant urinary protein has an excretion concentration of less than 20 mg/L (Dean et 
at. 2000). These authors have proposed that the true physiological concentration range 
of bikunin is 6.25 - 18 nmoi/L. Reports on urinary bikunin excretion in stone formers 
and healthy subjects are contradictory. The mean urinary bikunin concentration in one 
study was found to be higher in stone formers (5.2 j.Jg/ml) than in healthy subjects (2.8 
j.Jg/ml) (Suzuki et at. 2001 ). However, it was found to be higher in healthy controls than 
in stone formers in another study (5 mg/L and 2.54 mg/L respectively) (Medetognon-
Benissan eta/. 1999). 
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The role of bikunin as an inhibitor of CaOx crystall ization was first proposed by 
Nakagawa et a/. (1985). The effect of bikunin in its various urinary forms on CaOx 
crystallization has been tested in vitro. It has been reported that bikunin isolated from 
human urine is a strong inhibitor of CaOx crystallization (Hochstrasser et a/. 1984; 
Atmani et a/. 1993a; Atmani et a/. 1993b; Atmani et a/. 1995; Sorensen et a/. 1990). 
Many reports have demonstrated that bikunin inhibits CaOx nucleation (Hochstrasser 
et. a/. 1984; Atmani et a/.1999a; Atmani et a/. 1999b; Okuyama et a/. 1999); crystal 
growth (Atmani et a/. 1993; Atmani et a/. 1993b; Atmani et a/. 1999; Okuyama et a/. 
2003) and crystal aggregation (Atmani et a/. 1999). Bikunin isolated from the urine of 
stone formers has been found to be less glycosylated and showed less inhibitory effect 
than that purified from the urine of healthy subjects (Atmani et a/. 1994; Ebisuno et a/. 
1999). 
Regarding concentration , Atmani eta/. (1999) found that urinary bikunin retarded 
nucleation by 58 to 67 % at concentrations of 2.0 to 2.5 J.Jg/ml and inhibited crystal 
aggregation by 59 to 80 % at similar levels. In another study, it was demonstrated that 
bikunin fragments with molecular weights of 17 and 24 kDa inhibited CaOx 
crystallization in a concentration dependant manner, reaching 80 % at a concentration 
of 8 J.Jg/ml (Medetognon-Benissan eta/. 1999). Inhibition activity of 70 % was found in 
similar experiments with the intact 35 kDa protein at a concentration of 10 J.Jg/ml (Atmani 
et a/.1993). Bikunin can inhibit CaOx crystallization and alter the ratio of CaOx 
monohydrate (COM) to dihydrate crystallization (Wesson et a/. 1998). Kobayashi et a/. 
(1996) demonstrated that bikunin inhibits CaOx growth with increasing protein 
concentration when tested with a tracer of C4C]-oxalate. 
Bikunin has been implicated in the prevention of COM crystal adhesion to the 
renal ephithelial cells (Ebisuno et a/. 1999; Khan and Kok 2004; Yang et a/. 2005). In 
both studies Madine-Darby canine kidney (MOCK) cells were cultured and incubated 
with COM crystals in the presence and absence of various protein fractions isolated 
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from human urine. They demonstrated that a protein with a molecular weight of 35 kDa 
and an N-terminal sequence homologous to bikunin inhibits crystal adhesion at 
minimum concentrations of 10 ng/ml and blocked adhesion completely at 200 ng/ml. 
Bikunin is negatively charged and is thought to be a calcium-binding protein. Its 
inhibitory action against crystal adhesion depends on the binding of bikunin to the 
crystal surface (Eb1suno eta/. 1999). 
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1.8 OBJECTIVES 
As described earlier in this chapter, bikunin has been found to inhibit CaOx crystal 
nucleation, growth and aggregation. The present study was undertaken to compare the 
inhibitory effect of the urinary bikunin protein from black and white South African 
subjects on CaOx crystallization 
The objectives of this thesis were therefore: 
•!• To compare the relative baseline inhibitory activity of whole urine from healthy 
white and black South African subjects 
•!• To measure the relative inhibitory activity of commercially available bikunin in the 
urine of healthy subjects from both groups 
•!• To isolate COM and COD from the urines of healthy black and white subjects 
•!• To isolate protein precipitates (using ammonium sulphate) from the urines of both 
groups 
•!• To measure the inhibitory activity of the protein precipitate in the urine of healthy 
subjects from both groups 
•!• To analyze for the presence of bikunin in the protein precipitate, COM and COD 
matrix isolated from the urine of both groups 
•!• To isolate bikunin from the protein precipitated from the urines of both subjects 
•!• To characterize bikunin samples from both groups using SDS-PAGE, Western 
blot and MALDI-TOF MS 
•!• To measure the inhibitory activity of bikunin in the urine of healthy subjects from 
both groups using a cross-over design 
•!• To deglycosylate bikunin samples derived from the urine of both groups 
•!• To measure the relative inhibitory activity of the deglycosylated protein fractions 
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General Methods and Results 
2.1 Introduction 
This chapter describes the methods that were used in the different studies 
undertaken for this thesis. 
The urine collection and its treatment and CaOx metastable limit (MSL) 
determination methods are described. The inhibitory effects of proteins on CaOx 
crystallization in vitro were investigated using different crystallization experiments. 
These experiments measured C4C]-oxalate deposition and particle formation kinetics 
(particle number, particle volume and particle volume-size distribution). A scanning 
electron microscope (SEM) was also used to view deposited crystals. 
Also described in this chapter are the experiments used to determine the 
inhibitory activity of proteins towards CaOx crystal aggregation and nucleation in 
inorganic solutions. 
Finally, the general methods used for the protein characterization are 
described, namely sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) and protein concentration determination using the Bradford assay. 
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2.2 Methods 
2.2.1 Urine collection, treatment and determination of CaOx 
metastable limits 
For each of the studies described in this thesis, 24 hr urines were collected in plastic 
bottles without preservative from five black and five white healthy male subjects (age 
range 18-30 years) on their free unrestricted diets and with no history of kidney 
stones. The urines were tested for haematuria and nitrite using urinalysis test strips 
(Medi Test Combi 5N, Macherey-Nagel). The urines testing positive were excluded. 
Equal volumes (1 L) of the whole urines were pooled (Jappie and Rodgers 2000) 
according to race and 5 ml aliquots of each pooled sample were removed for 
compositional analyses. 
The urinary pH and volume were measured routinely and the urinary calcium, 
magnesium, potassium and sodium were determined using a Varian 1275 Model 
(Australia) flame atomic absorption spectrometer (Willis et a/. 1967, Trudeau and 
Freier 1967, Fernandez and Kahn 1971 ). Urinary oxalate was determined using 
oxalate decarboxylase (Chiriboga 1963), citrate by citrate lyase conversions to 
oxaloacetate (Gruber and Mollering 1966), and creatinine using picric acid (Rock et 
a/. 1986). Phosphate was determined using ammonium molybdate (Dryer and Routh 
1963) and uric acid using uricase (Fossati eta/. 1980). 
The supersaturation of urine with respect to CaOx, brushite and uric acid is a 
thermodynamic parameter which is most often expressed as the relative 
supersaturation (RS). The relative supersaturation values were calculated using 
EQUIL2, a speciation programme which computes the equilibrium concentrations of 
complexes of primary cations and anions commonly found in urine (Werness et a/. 
1985). The urine composition of the two race groups was compared using analysis 
of variance (ANOVA) and the results were considered statistically significant if p ~ 
0.05. 
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For crystallization experiments the pooled urines collected from the same population 
group were pre-filtered through 0.75 1-1m (Macherey-Nagel, Germany) followed by 
0.45 1-1m (Sartorius AG, Germany) nitrocellulose to remove debris and flocculents. 
The filtered pooled urine was then ultrafiltered (UF) through a 10 kDa cut-off 
membrane to remove all macromolecules greater than 10 kDa. The urine was 
incubated in a shaking water bath (1 00 rpm; Labcon Marketing Services, 
Johannesburg) at 37 °C and the metastable limit of the UF was measured according 
to the method described below. 
The CaOx metastable limit (MSL) was determined according to the method 
described by Ryall eta/. (1985). Briefly, 10 ml UF aliquots were pipetted into Coulter 
cups and incubated at 37 °C in a shaking waterbath (100 rpm) for 10 min. 
Thereafter, 100 IJL of solutions of increasing concentrations of Na20x (15 mmoi/L to 
195 mmoi/L) were used to dose the urines and these were incubated at 37 °C and 
100 rpm for 30 min. A Coulter Multisizer II (Coulter Electronic LTD; England) was 
used to measure the number of particles in each urine sample. 
A typical plot of particle number versus Na20x concentration is shown in 
Figure 2.1. The Na20x concentration that induces crystallization (shown by a 
sudden increase in the particle number) is regarded as a measure of the CaOx 
metastable limit of the urine. 
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Figure 2.1: Typical example of the graph for a CaOx MSL 
determination, where the concentration of Na20x 
corresponding to the red point indicated on the graph 
corresponds to a measure of the MSL. 
2.2.2 Crystallization experiments 
The following paragraphs describe experiments in which the inhibitory activity of 
"proteins" was investigated. This latter term is used generically to represent four 
different forms of bikunin, viz (i) commercial bikunin, (ii) protein precipitate containing 
bikunin (iii) purified bikunin and (iv) deglycosylated commercial bikunin. In all cases, 
a final protein concentration of 0.5 mg/L was used because it has been 
demonstrated that proteins extracted from urine inhibit CaOx crystallization by 80 % 
at this concentration (Doyle eta/. 1995). The treatment, isolation and purification of 
each of these forms of bikunin are described respectively in Chapters 3, 4, 5 and 7 of 
this thesis. 
Cross-over design 
A cross over design experiment (Craig et a/.1999) was used for the measurement of 
C4C]-oxalate deposition and particle formation kinetics and is illustrated in Figure 2.2. 
Once the MSL of the UF was determined, equal volumes were pipetted into three 
flasks. The ultrafiltered urine sample without added proteins was used as a control 
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in the C4C]-crystal deposition and particle formation kinetics experiments. Proteins 
were added to the other two flasks as shown in the Figure 2.2. 
BUF WUF 
l ~ 1 ~ 
BUF BUF + BP BUF + WP WUF WUF+ WP WUF + BP 
Figure 2.2: Cross-over design for crystallization experiments. BUF: pooled, 
ultrafiltered urine from black subjects; WUF: pooled, ultrafiltered urine from white 
subjects; BP: proteins from the urine of black subjects; WP: proteins from the urine of 
white subjects. 
Effect of proteins on {'4C]-oxalate deposition kinetics 
Crystal deposition experiments using radioactive [14C]-oxalate were conducted 
according to the method of Ryall et a/. (1995). These were used to determine the 
kinetics of CaOx crystallization as opposed to the kinetics of particle formation 
(described on page 38). 
Ultrafiltered urine samples from black and white subjects, referred to as WUF 
and BUF respectively, were divided into three 30 ml aliquots and incubated in a 
shaking waterbath at 37 °C for 10 min. Proteins were added to two of the flasks to 
achieve a final concentration of 0.5 mg/L. The third flask contained ultrafiltrate 
without protein and was used as a control. 0.938 IJCi of C4C]-oxalate (NEN, Boston, 
USA) was then added to each 30 ml aliquot and CaOx crystallization was induced by 
the addition of a sodium oxalate (Na20x) load 30 IJM above the previously 
determined MSL. 2.5 ml samples were withdrawn from each flask at 30 min intervals 
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and filtered through a 0.22 !Jm filter (Millipore) into 250 !JL concentrated HCI to 
quench the reaction. Duplicate 1 ml aliquots of the acidic solutions were added to 10 
ml scintillation fluid (Zinsser Analytic, Frankfurt) and counted in a liquid scintillation 
counter (LS 5000TD Scintillation Counter, Beckman Instruments) for 10 min each. 
The percentage of C4C]-oxalate deposited was determined from the equation: % 
precipitated C4C]-oxalate = 100- [100 x (cpm at x min/ cpm at 0 min)]. Graphs of 
this variable, i.e. percentage of precipitated C4C]-oxalate were constructed as a 
function of time. In order to facilitate interpretation of these graphs, trendlines 
corresponding to the gradient were computed. These are given on the right side of 
each curve. 
Effect of proteins on CaOx crystal aggregation and nucleation 
The aggregation assays (described in page on page 35) required slurries of COM 
crystals. The preparation of these crystals is described first. 
Preparation of calcium oxalate monohydrate (COM) crystals 
COM crystals were prepared by mixing equal volumes of 100 mM CaCI2 and 1 00 mM 
Na20x at a constant speed of 1 ml/min using a peristaltic pump (Pak et a/. 1975). 
The mixture was stirred at 4 °C for 7 days. The precipitated crystals were separated 
by filtration through 0.22 IJm filter paper, washed with distilled water followed by 
methanol and then dried at 95 °C for 1 hr. 
XRD analysis 
The crystals were analyzed by x-ray powder diffraction (XRD) (Phillips PW1 050/25 
goniometer) to ascertain whether they were COM or not. The interplanar d-spacing 
of the crystals were compared with the standard reference values for COM crystals 
(Sutor and Scheidt 1968). Figure 2.3 shows the XRD pattern of the crystals and the 
intensities. The observed peaks all corresponded to known COM reflections (Table 
2.1 ). 
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Figure 2.3: XRD pattern of CaOx crystals 
Table 2.1 : Reference XRD data of COM crystals together with the d-spacings (A) of 
prominent peaks observed experimentally 
Standard d-spacing and relative 
intensity data for COM 
d-spacing (A) Relative intensity 
5.93 100 
5.79 25 
4.64 7 
4.52 6 
3.78} 13 
3.76 
3.65 100 
3.00 10 
2.97 46 
2.91 12 
2.89 10 
2.84 14 
2.51 2 
2.48 30 
2.41 5 
2.37 2 
2.34 90 
Present study 
d-spacing (A) 
5.90 
3.64 
2.96 
2.90 
2.85 
2.48 
2.34 
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Aggregation assay 
Crystal aggregation was determined using the method developed by Hess et a/. 
(1989). A crystal slurry (0.8 mg/ml) was prepared by adding COM crystals (as 
prepared above) to a solution of 10 mM tris(hydroxymethyl)-aminomethane (Tris)HCI 
buffer, pH 7.2, containing 90 mM NaCI. The slurry was equilibrated with constant 
stirring at 1100 rpm for 16 hr in a glass vial at 37 °C. After equilibration of the slurry, 
it was mixed with proteins from both race groups in a 10 mm glass cuvette and 
incubated at 37 °C for 2 hr with stirring at 1100 rpm. Using a spectrophotometer 
(Specord 40, Analytikjena, Germany) the absorbance was monitored at 620 nm and 
37 °C for 15 min. The solution was stirred at 1000 rpm (corresponding to the 
maximum speed of the instrument) until equilibrium had been reached, which was 
demonstrated by a stable absorbance. Upon reaching equilibrium, stirring was 
stopped to induce aggregation. The sedimentation rate overtime (indicated by the 
"absorbance slope" in Figure 2.4) was measured which corresponded to the 
maximum rate of decrease in absorbance. A typical plot of such an experiment is 
shown in Figure 2.4. The percentage of crystal aggregation in the presence of 
proteins was calculated as (Ts!Tsc) x 100 where Tsc is the turbidity slope of the 
control without proteins and T s is the slope of the protein-dosed slurry. The inhibition 
of crystal aggregation (lA) data was calculated as 100 % - percent aggregation (Hess 
eta/. 1989). 
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Figure 2.4: A typical plot of absorbance vs time 
from which sedimentation rate was determined 
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Nucleation assay 
The method described by Hess et a/. (1995) was used. Stock solutions of 8.5 mM 
CaCiz and 1 mM NazOx, each containing 200 mM NaCI and 1 0 mM sodium acetate, 
pH 5.70, were prepared. The solutions were filtered (0.22 !Jm) before each 
experiment. Protein was added to solutions of calcium and oxalate in the volume 
ratio of 2:1 :2 (CaCiz: protein: Na20x). The mixture was equilibrated at 37 °C with 
continuous stirring at 500 rpm. The absorbance at 620 nm was measured every 0.5 
sec for 60 min at 37 °C using a spectrophotometer (Specord 40, Analytikjena, 
Germany). Figure 2.5 shows an example of a typical plot of absorbance versus time 
for this experiment. The percent nucleation inhibition induced by the proteins was 
determined from the equation: 
%Nucleation inhibition (In)= [1-Tsc ITs] x 100 where Tsc= turbidity slope of the protein 
sample and Ts= slope of the control without the protein. 
0.09 
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! 0.02 
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0 600 1200 1800 
Time (sec) 
2400 3000 
Figure 2.5: A typical plot of absorbance vs time for the 
nucleation experiment 
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Effect of proteins on particle formation kinetics 
A Na20x load, 30 IJM in excess of the previously determined MSL, was added to 
each of the three flasks, each contained 50 ml WUF or BUF. Proteins from both 
race groups were added to two of these flasks as shown in the cross over design 
(Figure 2.2). 
The urines were incubated at 37 °C in a shaking water bath (100 rpm) for 120 
min and the effect of the proteins on the particle volume-size distribution, particle 
number and particle volume was measured at 30 min time intervals for 120 min 
using a Coulter Multisizer II (140 1Jm orifice, 2.8 - 90.0 IJm particle size range, 256 
channels). Graphs of particle number and volume were plotted as a function of time. 
In order to facilitate interpretation of these graphs, gradients corresponding to the 
first 30 min of the crystallization processes were computed. Modes are reported for 
the particle size distribution curves. 
Scanning electron microscopy 
At the completion of the kinetics experiments described above, 2 ml of urine from 
each flask was passed through a 0.22 IJm filter to collect the deposited crystals. The 
filter paper was glued onto an aluminium stub for examination by scanning electronic 
microscopy. The crystals were then splutter-coated for 10 min with 3 - 5 nm of 
Au/Pd (Biorad, SEM coating system) and viewed using a Leica 8440 scanning 
electron microscope (Leica Cambridge Ltd , England) operating at an accelerating 
voltage of 10 kV, at a working distance of 10 - 15 mm and under a probe current of 
20- 30 pA. 
37 
Chapter Two 
2.2.3 Characterization of proteins 
Determination of urinary protein concentration 
In the experiments involving protein precipitates (Chapters 4 and 5). The Bradford 
assay method was used to measure the protein concentration (Bradford 1976). For 
the construction of a standard curve, duplicate samples of bovine serum albumin 
(BSA) were prepared in the concentration range 1 IJg/ml - 20 IJg/ml. Each sample 
contained 800 Ill protein and 200 J.il protein assay solution (BioRad). The mixtures 
were incubated for 5 min in eppendorf tubes. The absorbance was then measured at 
595 nm (UV-vis Spectrophotometer, Anthelie) in disposable plastic cuvettes. The 
absorbance of BSA measured at different concentrations using the Bradford protein 
assay are presented in Table 2.2. The standard curve corresponding to these results 
is shown in Figure 2.6. 
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Table 2.2: BSA standard curve data 
Concentration Average Absorbance 
(IJg/ml) 
1 
2 
3 
4 
5 
20 
1.2 
- 1 E 
c 
II) m o.8 
-3 0.6 
c 
nl 
€ 0.4 
i 
~ 0.2 
0 
0 
(595 nm) 
0.07 
0.14 
0.19 
0.26 
0.33 
1.06 
Figure 2.6: BSA standard curve 
5 10 
pg/ml 
±SE 
0.0032 
0.0152 
0.0021 
0.0089 
0.0059 
0.0023 
y = 0.0512x + 0.0428 
R2 = 0.9972 
15 20 
Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis 
(SDS-PAGE) 
Using BioRad Mini-Protean II apparatus (BioRad Laboratories, Hercules, California, 
USA), the protein precipitate from each population group was analysed by 10 % 
SDS-PAGE (Methods in Appendix 1 ). 
Samples containing 0.5 mg proteins were diluted in 15 !JL distilled water and 1.5 !JL 
5 x SDS reduction buffer. The samples were boiled for five minutes and were 
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allowed to cool down prior to electrophoresis. A low range molecular weight marker 
was included (Bio-Rad). Proteins were resolved on 10 % polyacrylamide mini gels by 
electrophoresing at 25 rnA per gel until the dye-front had run off the gel. Protein 
bands were detected by staining with Coomassie Blue (0.05% Coomassie Blue, 50 
% methanol and 7 % acetic acid) for 1 hr, after which the background was destained 
(25% ethanol and 7% acetic acid) for approximately 30 min. 
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2.3 Results 
Since urinary compositions and CaOx metastable limits were measured in all of the 
different studies in this thesis, results for these determinations are reported here. 
Results for specific studies are presented in the relevant chapters which follow. 
2.3.1 Urine composition 
Table 2.3 shows the average composition values and physicochemical parameters 
obtained for 20 pools of urine, each pool consisting of five urine samples from black 
and white subjects. The data for each pooled urine sample is shown in Appendix 1 
· [Black subjects: Tables A 1.1, White subjects: Table A 1.2 for commercial bikunin 
experiments], Appendix 2 [Black subjects: Tables A2.1 , White subjects: Table A2.2 
protein precipitate experiments], Appendix 3 [Black subjects: Tables A3.1, White 
subjects: Table A3.2 for isolated bikunin experiments] and Appendix 4 [Black 
subjects: Tables A4.1 , White subjects: Table A4.2 for bikunin deglycosylation 
experiments]. 
Table 2.3: Average composition and physicochemical parameters of pooled urine 
samples from black (B) white (W) subjects 
15.5 ± 1.9 16.7 ± 1.9 
556 ± 35 580 ± 35 0.629 
59.1 ± 3.7 64.6 ± 3.7 0.304 
9.47 ± 1.20 12.38 ± 1.20 0.095 
1.20 ± 0.14 1.16 ± 0.14 0.821 
78.1 ± 6.64 101 .7 ± 6.64 0.016* 
117 ± 26 229 ± 26 0.004* 
17 ± 126 0.043* 
RS Uric acid 
*Difference is statistically significant: pSO. 05. RS: relative supersaturation 
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2.3.2 CaOx metastable limit 
Figure 2. 7 gives mean plots for the determination of the CaOx MSL in 20 pooled 
urine from black (Figure 2.7.1) and 18 pooled urine from white (Figure 2.7.2) 
subjects. These graphs show that the metastable limit in the urine of black subjects 
is higher than that in white subjects i.e. 0.075 vs 0.045 mol.dm-3 respectively. The 
data and plots for each pooled urine sample are shown in Appendix 1 [Black 
subjects: Tables B 1.1 and Figures A 1.1, White subjects: Tables B 1.2 and Figures 
A 1.2 for commercial bikunin experiments], Appendix 2 [Black subjects: Tables B2.1 
and Figures A2.1, White subjects: Tables B2.2 and Figures A2.2 for protein 
precipitate experiments], Appendix 3 [Black subjects: Tables B3.1 and Figures A3.1, 
White subjects: Tables B3.2 and Figures A3.2 for isolated bikunin experiments] and 
Appendix 4 [Black subjects: Tables 04.1 and Figures E4.1, White subjects: Tables 
04.2 and Figures E4.2 for bikunin deglycosylation experiments]. 
42 
Chapter Two 
Figure 2. 7.1: Mean plot from black subjects 
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Figure 2.7.2: Mean plot from white subjects 
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2.3.3 Crystallization assays 
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Results for the various crystallization experiments involving the different forms of 
bikunin are presented in Chapters 3, 4, 5 and 7. 
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2.4 Discussion 
The results for the 24 hr urine composition analysis (Table 2.3) showed that calcium 
is significantly lower in black subjects' urine. This confirms previous reports that the 
South African black race group has a significantly lower urinary calcium 
concentration than the white group (Whalley et a/. 1998; Lewandowski et a/. 2002). 
Other differences were also observed in the urine chemistry of black and white 
subjects in the present study. For example, phosphate and potassium were 
significantly lower in black subjects' urine. These differences were also observed in 
another study (Lewandowski et a/. 2002). While the lower calcium concentration in 
black subjects is noteworthy, values nevertheless lie in the normal range. Thus the 
observed urinary differences do not explain the low occurrence of stones in the 
South African black population. Contrary to what has been reported in another study 
where it was demonstrated that citrate is significantly lower in black South African 
subjects (Lewandowski et a/. 2002), the present study did not observe any 
differences between the urines of the two race groups with respect to this parameter. 
Sodium was also found to be significantly lower in black subjects' urine in the 
present study. Contrary to this, Modlin (1968) reported a higher sodium excretion in 
blacks and suggested that sodium can act as an inhibitor of calcification by 
increasing the solubility of calcium. 
Surprisingly, the relative supersaturation of CaOx in the two race groups was 
not statistically significant. As such, it might have been expected to be lower in the 
urine of black subjects because of the rarity of stones in this population group. 
Relative supersaturation is the prerequisite for the occurrence of crystallization in 
urine. Other studies have also not identified any differences in this important 
physicochemical property, thereby demonstrating that routine urine parameters 
alone are unlikely to provide an explanation for the rarity of stones in the black 
population (Lewandowski et a/. 2002; Webber et a/. 2003). Notwithstanding this 
point, the relative supersaturation of brushite in the present study was significantly 
lower in black subjects. This is interesting because brushite has been mooted as an 
initiating nidus in CaOx stone formation (Pak eta/. 1984). 
44 
Chapter Two 
Several previous studies have indicated that proteins do not have an effect of the 
CaOx metastable limit (Grover et a/. 1990, 1994; Ryall et a/. 1995; Edyvane et at. 
1997). As such, the present study simply compared the metastable limit of the two 
race groups without addition of proteins. These determinations showed that the MSL 
in black subjects in higher than in white subjects, thereby confirming that inducing 
CaOx crystallization in the urines of the former group is more difficult to achieve. 
These results are in agreement with the lower occurrence of urolithiasis in this group 
(rv >dhn 1968; Whalley e1 at. 1998; Rodgers et at. 2 16). 
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Inhibitory Activity of Commercial 
Bikunin 
3.1 Introduction 
As stated in Chapter 1, the primary objectives of the present project are to compare 
the relative inhibitory capacity of bikunin, isolated and purified from the urine of black 
and white South African subjects, in a host of different crystallization experiments 
and also to examine the effect of the urine environment on these capacities. As a 
strategic starting point, it was decided to develop, test and implement the various 
assays using commercially available bikunin (CB) rather than bikunin derived from 
both race groups. Besides enabling the establishment of the assays themselves, 
this approach allowed investigation of the protein's inhibitory performance in the 
urines of the respective groups. This chapter describes these experiments. 
Objectives 
The objective of this initial study was to conduct a variety of crystallization 
experiments in the urine of black and white South African subjects using 
commercially available bikunin in order to test the different assays and also to 
investigate whether the nature of the urine milieu has any influence on the capacity 
of this protein to inhibit CaOx crystallization processes. 
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3.2 Methods 
3.2.1 Crystallization experiments 
Urine collection and treatment 
The urine that was used in these particular crystallization experiments was collected 
and pooled as previously described in Chapter 2.2.1, page 29. Five pools of urine 
were collected from black subjects and 3 pools from white subjects. The CaOx 
metastable limit of the urines was determined using a method previously described 
in Chapter 2.2.1, page 30. To assess the experiments' reproducibility, all the 
crystallization experiments presented in this chapter were performed in duplicate. 
Effect of Commercial bikunin CB on ( 4C}-oxalate deposition 
The C4C]-oxalate deposition experiments were carried out as described in Chapter 
2.2.2, page 32. "CB1" and "CB2" refer to a duplicate experiments using commercially 
available bikunin. 
Effect of CB on crystal aggregation 
The spectrophotometer-based assay described in Chapter 2.2.2, page 35 was used 
to study the effect of the UF and CB on COM crystal aggregation in UF from the two 
race groups. The combinations of COM+CB, COM+BUF, COM+WUF, 
COM+BUF+CB and COM+WUF+CB were investigated. 
Effect of CB on crystal nucleation 
CaOx nucleation was studied in the absence and presence of CB as follows: C+CB, 
C+BUF, C+WUF, C+BUF+CB and C+WUF+CB where C is the control (CaCb + 
NazOx containing solutions). The method is explained in detail in Chapter 2.2.2, 
page 36. 
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Effect of CB on particle formation kinetics 
Particle number-volume-size distribution 
A Coulter Counter was used to determine the particle number-volume-size 
distributions in BUF and WUF before and after dosing with CB at a final 
concentration of 0.5 mg/L using the method previously described in Chapter 2.2.2, 
page 37. SEM was used to view the crystals precipitated as described in Chapter 
2.2.2, page 37. 
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3.3 Results 
3.3.1 Crystallization experiments 
Effect of CB on ('4C]-oxalate deposition 
Two unambiguous, reproducible results emerged form these experiments. Firstly, 
the total amount of CaOx crystals deposited after 90-120 min was significantly 
reduced when CB was added. In BUF, the reduction was 6 % while in WUF the 
reduction was 15 %. Secondly, the rate of CaOx deposition (as indicated by the 
gradient of the respective kinetics graphs) was also significantly reduced by the 
addition of CB. The magnitude of this effect was again greater in WUF. Typical 
plots are given Figure 3.1.1 and 3.1.2. The data for each of the five experiments is 
shown in Appendix 1 (Black subjects: Table C1.1 and Figure 81.1; White subjects: 
Table C1.2 and Figure 81.2). CB reduced [14C]-oxalate deposition as demonstrated 
in Figure 3.1. 
49 
40 
-! 35 
= 30 9 
.P' 25 
... 
..... 
) 20 
·- 15 Q. 
·~ 10 
D. 
<fl. 5 
45 
~ 40 
= 35 
9 30 
.P' 
~ 25 j 20 
·a 15 
·~ 10 
D. 
<fl. 5 
0 30 
0 30 
C h a p t e r Three 
Figure 3.1.1 
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Figure 3.1: A typical plot of [14C] - oxalate experiments of BUF 
(Figure 3.1.1) and WUF (Figure 3.1.2) urine before and after 
addition CB 
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Comments: 
The results in these experiments show that CB inhibits the deposition of CaOx 
crystals in the urine of both race groups and that the decrease in WUF was greater 
than in BUF. Since differences in the chemical composition of WUF and BUF have 
already been highlighted, the [14C]-deposition experiments have demonstrated that 
the nature of the urine milieu affects the capacity of CB to moderate the amount of 
CaOx deposition as well as its rate of formation. 
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Effect of CB on crystal aggregation 
In all of these experiments, the addition of CB to a slurry of COM crystals inhibited 
aggregation significantly (range 85-97 %, mean 91 %) p<0.05. Table 3.1 gives the 
actual percentage inhibition values obtained in five experiments while the mean plot 
for these in shown in Figure 3.2. The plots for each experiment are shown in 
Appendix 1 (Figure C1.1 ). 
Table 3.1: Absorbance slopes of COM crystal slurries before and after addition of 
CB and percent inhibition of aggregation (% lA) 
Sample Absorbance slope % lA 
(x10-5 s-1) (R2) ± SE 
COM+CB1 85 
COM+CB2 88 
COM+CB3 94 
COM+ CB4 92 
COM+ CBS 97 
Avera e: COM+CB 91 
-+- COM 
- cOM+CB 
0 150 300 450 600 750 900 
Time (sec) 
Figure 3.2: A typical plot of absorbance vs time of COM slurry 
before and after addition of CB. Arrows indicate the time at 
which stirring was stopped to induce crystal aggregation 
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Recognizing that urine is the chemical medium in which in vivo crystallization 
process occur, the effect on aggregation of CB in combination with UF was also 
tested. Average absorbance slopes and percent inhibition are shown in Table 3.2. 
The data and plot for each of these experiments are given in Appendix 1 (Black 
subjects: Table 01.1 and Figure 01.2; White subjects: Table 01.2 and Figure 01 .3). 
Table 3.2 shows that the mean percent inhibition when UF alone was added 
to the crystal slurry was 47 and 54 % for black and white subjects, respectively. 
These values increased significantly to 60 % in black subjects when CB was 
included in the mixture but insignificantly 56 % in white subjects. Figure 3.3 shows 
a typical plots for the change in absorbance in the presence and absence of CB and 
BUF (Figure 3.3.1) and WUF (Figure 3.3.2). These plots indicate that the addition of 
CB greatly reduced the sedimentation rate. 
Table 3.2: Absorbance slopes and percent inhibition of aggregation (% IA).of COM 
crystal slurries before and after addition of CB and UF 
Sample Absorbance slope 
(x1o-ss-1) (R2) 
%lA Average 
Duplicate Duplicate 
COM (n=5) -519 (0.998) 
COM+CB (n=5) -44 (0.943) - 91 - 91 
COM+BUF(n=5) -296 (0.987) -298 (0.991) 47 47 47 
COM+BUF+CB (n=5) -196 (0.987) -220 (0.987) 62 58 60 
COM+WUF (n=3) -238 (0.996) -245 (0.925) 54 53 54 
COM+WUF+CB (n=3) -230 (0.996) -229 (0.973) 56 56 56 
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Figure 3.3.1 
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Figure 3.3: Plot of absorbance vs time of the sedimentation 
experiment before and after addition of CB and UF. 
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Comments: 
It is evident from the aggregation experiments that CB is a strong inhibitor of crystal 
aggregation. This was demonstrated by a significant percent inhibition of 91 %when 
CB was added to COM crystals. When comparing the two race groups, superior 
aggregation inhibition was demonstrated in the urine of black subjects after addition 
ofCB. 
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Effect of bikunin on nucleation 
In these e xperiments, addition of CB to the control inhibited nucleation of CaOX 
ange 36-60 %, mean 50 %). Individual values for each of the five 
s are shown in Table 3.3 while a typical plot of absorbance vs time for 
riments is given in Figure 3.4. The data and plots for each experiment 
n Appendix 1 (Figure E1 .1). 
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Table 3.4 shows that when ultrafiltered urine was added, inhibition of nucleation 
increased dramatically to values 2':: 90 %, irrespective of whether CB was included or 
not (p<0.05). The data and plots for each of these experiments are shown in 
Appendix 1 (Black subjects: Table E1.1 and Figure E1 .2; White subjects: Table E1.2 
and Figure E1.3). Typical plots of absorbance vs time for these experiments are 
shown in Figure 3.8. 
Table 3.4: Absorbance vs time slopes and percentage inhibition of nucleation (% In) 
for the control solution (CaCI2 + Na20x) after addition of CB, BUF and WUF 
Sample Absorbance slope 
(x1 o-s s -1) (R2) 
%In Average 
Duplicate Duplicate 
Control (C) (n=5) 47.1 (0.990) 
C+CB (n=5) 23.4 (0.961) - 50 - 50 
C+BUF (n=5) 3.29 (0.972) 3.01 (0.901) 93 94 94 
C+BUF+CB (n=5) 2.80 (0.971) 5.42 (0.988) 92 89 90 
C+WUF (n=3) 3.01 (0.965) 2.80 (0.988) 94 94 94 
C+WUF+CB (n=3) 2.70 (0.979) 2.00 (0.899) 92 96 94 
57 
0014 
e oo12 
c 
0 001 
N 
!!. 0 08 Q) 0 
u 
C h a p t e r Three 
Figure 3.5.1 
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Figure 3.5: Average plot of absorbance vs time for the 
nucleation experiment before and after addition of CB , BUF 
(Figure 3.5.1) and WUF (Figure 305.2) 
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Comments: 
The results of these experiments are highly interesting because, although CB was 
shown to be on inhibition of nucleation, ultrafiltered urine alone was far superior in 
th is regard. Moreover, the addition of CB together with UF did not produce an 
additional effect. Thus it can be speculated that in vivo, CB has little effect, if any, on 
CaOx nucleation. 
59 
C h a p t e r Three 
Effect of CB on particle formation kinetics 
Particle size distribution 
Particle size distribution curves were unimodal in four of five BUF samples and 
bimodal in all three of the WUF samples. Modes for these distributions are given in 
Table 3.5 while typical curves are given in Figure 3.6. Plots for each experiment at 
30 min intervals are given in Appendix 1 (Blacks: Figure F1.1, Whites: Figure F1.2). 
Addition of CB caused a shift in the mean size distribution to smaller value in both 
BUF and WUF (Table 3.5). However, the bigger mode in WUF was not significantly 
affected. 
Table 3.5: Particle size (IJm) of ultrafiltered urine from black (BUF) and white (WUF) 
subjects before and after addition of CB at final concentrations of 0.5 mg/L 
BUF BUF+CB1 BUF+CB2 
Experiment 1 5.4 and 16.0 5.46 and 17.2 3.28 and 17.1 
Experiment 2* 6.9 4.7 5.8 
Experiment 3* 5.8 5.5 5.1 
Experiment 4 * 3.6 3.3 -
Experiment 5* 6.0 2.0 -
WUF WUF+CB1 WUF+CB2 
Experiment 1 * 4.4 and 12.4 3.3 and 16.1 4.1 and 16.7 
Experiment 2* 3.6 and 26.3 3.3 and 26.2 2.9 and 24.8 
Experiment 3 3.6 and 22.6 4.0 and 22.9 3.9 and 23.2 
*Trend showing a decrease 
Experiments 4 and 5 were not completed in duplicate 
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Figure 3.6: Typical particle size (J.Jm) plot of ultrafiltered 
urine from black (Figure 3.6.1) and white (Figure 3.6.2) 
subjects before and after addition of CB. 
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Comments: 
The observation of bimodal size distribution in WUF but not in BUF is interesting as it 
consisted with the notion that larger crystals are synonymous with stone disease. 
This in turn , is consisted with the higher incidence of stones in the white population. 
The shift to smaller sizes in the pressure of CB suggests that the protein has the 
capacity to be an inhibitor of CaOx growth. However, this cannot be conclusive 
since the shifts in particle sizes were not statistically significant. 
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SEM 
Figure 3.7 shows the SEM micrographs of CaOx crystals precipitated from the BUF 
and WUF before and after addition of CB. The crystals were all viewed at 4K 
magnification. As depicted in Figure 3.7.1 crystals in BUF have COM morphology. 
The particle number reduced slightly after addition of CB and crystals appeared 
larger in relation to BUF (Figure 3.7.2). Crystallization in WUF demonstrated a 
predominantly COD morphology although COM crystals were also observed (Figure 
3.7.3). Figure 3.4.4 shows that there was a slight decrease in the particle number 
and accompanied by an increase in the particle size after addition of CB. No 
morphology change was observed when CB was added to either BUF or WUF, nor 
was there any evidence of aggregation, both before and after addition of CB. 
Figure 3.7: SEM of CaOx crystal deposition in BUF before 
(Figure 3.7.1) and after addition of CB (Figure 3.7.2) and WUF 
before (Figure 3.7.3) and after addition of CB (Figure 3.7.4). 
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Comments: 
The observation of COM crystals in BUF and COD crystals in WUF is in agreement 
with previously reported studies (Webber eta/. 2003). The observation itself is not 
surprising since COD crystals are known to form at higher calcium concentration 
(Cerini et a/. 1999). Indeed, the present study (and others) has shown that white 
subjects have higher urinary calcium than their counterparts (Chapter 2, Table 2.3). 
The observation that particle size appeared to increase after addition of CB is in 
conflict with the (non significant) decrease in size suggested by the distribution 
curves in Figure 3.6, thereby ruling out the possibility of CB being an inhibitor of 
CaOx growth. 
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Particle number 
Particle numbers at 120 min generally decreased in both BUF and WUF when CB 
was added, although increases were observed in some experiments. Initial particle 
formation kinetics, as determined by the gradients during the first 30 min, also 
showed decreases after addition of CB. Typical kinetic plots of particle number vs 
time are presented in Figure 3.8. Linear expressions for the gradients in the first 30 
min are given on the right hand side of each curve. The data and plots for the each 
experiment are shown in Appendix 1 (Black subjects: Table F1 .1; Figure G1.1, White 
subjects: Table F1.2; Figure G1.2). 
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Figure 3.8: Plots of particle number in BUF (Figure 3.8.1) and WUF 
(Figure 3.8.2) before and after addition of CB at a final concentration 
of 0.5 mg/L. The linear expressions for the first 30 min (BUF) and 30 
min (WUF) are given on the right hand side of each curve. 
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Comments: 
During the particle counting process, the Coulter instrument is unable to distinguish 
between agglomerate of many small crystals and a single individual crystal. In both 
cases, a count of "one particle" will be registered. Thus, if agglomeration or 
disaggregation occurs during the crystallization experiments (as is likely) fluctuations 
in the particle count will be observed. Indeed, this did occur. As a result, 
interpretation of the data proved to be difficult. Nevertheless, general observations 
were possible. Thus, while identical trends for particle numbers and formation 
kinetics were not observed throughout, most of the experiments showed a decrease 
in particle number when CB was added to BUF and WUF. This suggests that CB has 
the capacity to either inhibit nucleation or promote aggregation. The experiments 
were not able to distinguish between BUF and WUF with regard to their respective 
roles in the crystallization process. 
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Particle volume 
Three of five experiments showed a decrease in the particle volume when CB was 
added to BUF. When CB was added to WUF, two of three experiments 
demonstrated an increase in the particle volume. Figure 3.9 shows typical particle 
volume plots before and after addition of CB at a final concentration of 0.5 mg/L. 
The data and plots for each experiment at 30 min intervals are presented in 
Appendix 1 (Black subjects: Table G1.1 , Figure H1.1 , White subjects: Table G1.2, 
Figure H1 .2). As with the particle number experiment the gradients were included in 
order to facilitate the interpretation. 
68 
C h a p t e r Three 
Figure 3.9.1 
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Figure 3.2: Typical plots of particle volume of 
ultrafiltered urine from BUF (Figure 3.9.1) and WUF 
(Figure 3.9.2) subjects before and after addition of CB 
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Comments: 
When comparing the effect of CB on the particle volume in the ultrafiltered urines of 
the two race groups, it was observed that particle volume decreased when CB was 
added to BUF but increased when added to WUF. It is appropriate at this point to 
interpret the significance of an increase or decrease in particle volume. An increase 
in particle volume can occur as a consequence of the following processes. 
i) an increase in nucleation 
ii) disaggregation of existing clusters 
iii) aggregation of existing particles with a concomitant inclusion of air pockets 
and urine debris. 
Conversely, a decrease in particle volume can occur as a consequence of the 
following processes: 
i) a decrease in nucleation 
ii) aggregation of existing particles with 100 % efficiency, i.e without the 
entrapment of air and urine debris 
Since the latter (i.e. aggregation with 100 % efficiency) is unlikely to happen, it can 
be reasonably concluded that a decrease in particle volume occurs as a result of a 
decrease in nucleation. Thus the effect of CB in BUF can be interpreted in this way. 
Since CB caused an increased in particle volume in WUF, one of the three 
processes mentioned above must be occurring. However in the Coulter experiment 
on particle number (pages 66-68), nucleation was observed to decrease indicating 
that either of the other two mechanisms is occurring i.e disaggregation of existing 
clusters or aggregation with entrapment. Since the earlier study described on pages 
53-56 showed that CB inhibits aggregation, the volume increase can be attributed to 
this mechanism. 
Regarding the kinetics of particle volume change, Figure 3.9.1 demonstrates 
that addition of CB to BUF decreased while Figure 3.9.2 showed an increase of the 
rate in WUF. 
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3.4 Discussion 
As stated in the objectives for this particular set of experiments (page 47), it was 
decided to test various crystallization assays for their efficacy and practicability. 
These tests revealed that the C4C]-oxalate deposition experiments, as well as those 
which investigated CaOx crystal sedimentation (to provide information about 
aggregation and nucleation mechanism) did indeed satisfy these criteria. In addition, 
scanning electron microscopy provided very useful visual data. However, as 
discussed earlier, Coulter Counter data proved to be difficult to interpret. In addition 
to the limitations of this technique which have already been mentioned, an additional 
short coming relates to its inability to distinguish between particles and crystals. As 
such, the data obtained using the Coulter Counter was interpreted as the effect of 
CB on the "particle" as opposed to "crystals". These particles or crystals could be 
single or aggregated and may or may not include organic debris. Thus an increase 
or decrease in the particle number and volume cannot be confidently attributed to the 
formation of the CaOx crystals. Therefore these experiments had to be 
supplemented with SEM and C4C]-oxalate deposition experiments since they involve 
crystal formation. Nevertheless, despite the shortcomings in the Coulter technique, it 
was decided to retain this assay, recognizing that interpretation would present 
unique challenges. 
Regarding the role of CB in modulating CaOx crystallization mechanisms, 
sedimentation experiments showed it to be an inhibitor of nucleation was supported 
by C4C]-oxalate deposition experiments and by Coulter number data, albeit that the 
latter showed inhibition of particle formation rather than CaOx "crystal" formation. 
This is in agreement with other in vitro studies (Hochstrasser et. a/. 1984; Atmani et 
a/.1999a). 
Sedimentation experiments in the present study showed that CB is an 
inhibitor of CaOx crystal aggregation and this is in agreement with literature in vitro 
studies where it was reported that bikunin is a strong inhibitor of CaOx aggregation 
(Atmani eta/. 1999). 
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Although Coulter size distributions studies indicated that CB may be an inhibitor of 
CaOx crystal growth because it caused a shift in the mode to smaller sizes, this 
notion was not supported by SEM which showed an increase in particle size after 
addition of the protein. 
A further objective in this particular study was to investigate whether the 
different urine milieus associated with BUF and WUF might influence the role of CB. 
However, prior to discussing the results pertaining to such an effect, attention is 
drawn to the marked differences between BUF and WUF independent of the 
presence of CB. Firstly, Coulter size distribution showed that after administration of 
sodium oxalate loads to initiate crystallization, two size modes occurred in WUF 
while only one such mode occurred in BUF. This itself is very interesting as 
Robertson (1968) in his pioneering study using a Coulter Counter reported two 
modes in stone formers' urine. However, irrespective of Robertson results, the 
observation of a second mode (in larger size range) in WUF but not in BUF is 
consistent with stone formation being common in the former group but rare in the 
latter group. Secondly, SEM demonstrated the formation of COD while COM formed 
in BUF, after addition of sodium oxalate. This too is interesting because COD 
crystals have been reported as having a lower capacity for attachment to renal cells 
( esson eta/ 1998). Since the latter is a risk for stone formation , the observation of 
COM in BUF is consistent with the lower stone incidence in the black group. Thus 
fundamental differences exist between BUF and WUF. These differences indeed 
influence the activity of CB in modulating CaOx crystallization. 
Compelling evidence in this regard was provided by the C4C]-oxalate 
deposition measurements, the sedimentation experiments and the Coulter particle-
volume data. The deposition experiments showed that the effect of CB in reducing 
CaOx formation was greater in BUF; finally Coulter particle volume studies showed 
that CB inhibits nucleation in BUF and aggregation in WUF. These results clearly 
show that the nature and chemical composition of the urine influences the 
performance (and role) of CB with respect to its capacity for modulating CaOx 
crystallization processes. This effect has not been previously reported for CB. 
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Chapter 4 
Protein Precipitates and their Effects 
on CaOx Crystallization Processes 
4.1 Introduction 
As part of the strategic approach for the ultimate study of purified urinary bikunin 
from black and white subjects, the second series of experiments which were defined 
for this thesis involved the investigation of the effects of protein precipitates 
containing bikunin, rather than the protein itself. This chapter describes the 
preparation of these precipitates and their application in crystallization experiments 
similar to those in the previous chapter. 
Objectives 
•:• To prepare protein precipitates from the urines of healthy black (BPP) and 
white (WPP) subjects 
•:• To characterize the protein precipitates using SDS-PAGE 
•:• To test and compare the relative inhibitory activities of the protein precipitates 
in CaOx crystallization experiments as described in Chapter 3, but to include 
cross-over investigations 
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4.2 Methods 
4.2.1 Urine collection and treatment 
Twenty-four hour urine samples were collected tested and pooled as previously 
described in Chapter 2.2.1, page 30. In addition, for the preparation of protein 
precipitate, the pooled urine samples were extensively dialyzed against distilled 
water for 2 days using a 1 0 kDa cut-off membrane at 4 °C to remove urea, small 
glycosaminoglycans and peptides. 
4.2.2 Protein precipitation 
Protein precipitation using ammonium sulphate is a simple and easy method 
particularly when large volumes of urine are involved, and it is therefore widely used 
for preparative protein separation (Bell et a/. 1983; Jiang et at. 2004; Yang et at. 
2005). Proteins are soluble in -aqueous solutions but at high salt concentrations 
most are insoluble. As such they will precipitate out of the salt solution by separating 
from the solution as a solid. Thus the strategy of protein precipitation using a high 
ammonium sulphate concentration was employed in the present study to obtain a 
mixture of proteins from urine. 
Precipitation was induced by slow addition of ammonium sulphate (80 % 
saturation, 516 g/L) to the dialyzed urine with continuous stirring (Bell eta/. 1983). 
The suspension was stirred for 1 hr and left to stand overnight at 4 °C. The 
suspension was then centrifuged for 30 min at 15 000 g (Beckman, JA-14). The 
pellet was washed with 90 % cold acetone, kept on ice for 15 min and centrifuged for 
another 30 min at 15 000 g. The supernatant was then discarded and the precipitate 
was dissolved in -50 ml distilled water and dialyzed against distilled water overnight 
at 4 °C. 
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4.2.3 Crystallization experiments 
Urine collection and CaOx metastable limit 
CaOx metastable limits in the collected urines were determined as described in 
Chapter 2.2.1, page 30. Five pooled of urines were collected from both black and 
white subjects for the crystallization experiments presented in this chapter. 
Effect of BPP and WPP on f 4C]-oxalate deposition 
The C4C]-oxalate deposition experiments before and after addition of BPP and WPP 
were carried out as described in Chapter 2.2.2, page 31. However, cross-over 
experiments, as described in Chapter 2.2.2, page 32 were included 
Effect of BPP and WPP on crystal aggregation 
The effect of BPP and WPP on the aggregation of COM crystals was determined 
using a method described in Chapter 2.2.2, page 35. 
Effect of BPP and WPP on crystal nucleation 
Nucleation assay was conducted in the absence and presence of BPP and WPP as 
described in Chapter 2.2.2, page 36. 
Effect of BPP and WPP on particle formation kinetics 
The effect of BPP and WPP on particle size, volume and number was tested as 
described in Chapter 2.2.2, page 37. 
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4.2.4 Characterization of protein precipitates 
Protein concentration were determined using the Bradford assay as described in 
Chapter 2.2.3, page 38, while SDS-PAGE was used to identify the presence of 
bikunin (and other proteins) as described in Chapter 2.2.3, page 39. 
4.3 Results 
4.3.1 Isolation and characterization of protein precipitates 
SDS-PAGE 
The proteins precipitated from the urine using ammonium sulphate precipitation were 
analyzed by SDS-PAGE and stained with Coomassie Blue as shown in Figure 4.1. 
Figures 4.1.1 and 4.1.2 show the protein precipitates from both black (BPP) and 
white (WPP) subjects, respectively. The marker is included to estimate the molecular 
masses of the proteins. 1 mg protein (in 20tJL) was loaded for both BPP and WPP. 
The protein precipitates from both race groups were qualitatively similar and both 
revealed a prominent band at -60 kDa. Other protein bands were also observed at 
-25, 30, 45 and 120 kDa. 
Figure 4.1.1 
BPP M kDa 
~120 
~97 
~66 
~45 
~30 
~20 
Figure 4.1 .2 
WPP M kDa 
.__120 
.__97 
.---66 
.---60 
4 45 
.---20 
Figure 4.1: 10 % SDS-PAGE of proteins precipitated from the 
urines of black (Figure 4.1.1) and white subjects (Figure 4.1.2). 
Lane M is the low molecular weight marker. 
7C: 
C h a pte r Four 
Protein concentration determination 
Table 4.1 shows the total concentration of proteins precipitated from 5 pooled urines 
from black and white subjects (each pool consisting of a 24 hr urine sample from 5 
subjects). A large within-group range was observed in both population groups. The 
total protein concentration for black and white subjects was found to be 20.20 and 
16.10 mg/L, respectively. 
Table 4.1: Protein precipitate concentration (mg/L) from black and white subjects' 
urine 
Sample Protein Sample Protein 
concentration concentration 
(mg/L) (mg/L) 
BPP1 10.00 WPP1 8.80 
BPP2 23.25 WPP2 9.62 
BPP3 11.60 WPP3 12.50 
BPP4 19.20 WPP4 26.41 
BPP5 26.02 WPP5 15.30 
Average± SE 20.20 ± 3.16 Average± SE 16.10 ± 3.16 
Comments: 
The major band at -60 kDa observed in the protein precipitate derived from the urine 
of both black and white subjects is likely to be due to albumin, the second most 
dominant protein in urine (Grover eta/. 1998). There were no significant differences 
(p>0.05) observed in the total protein concentration derived from the two race 
groups. These concentrations all fell within the range reported in the literature 
(Ebisuno eta/. 1999; Khan and Kok 2004). 
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4.3.2 Crystallization experiments 
Effect of BPP and WPP on {'4C]-oxalate deposition 
The results of these experiments showed that addition of the protein precipitate, 
irrespective of its origin, and irrespective of the urine in which it was tested 
decreased the percentage of [14C]-oxalate deposition. This is shown in Figures 4.2.1 
(BUF) and 4.2.2 (WUF). Of interest was the consistent observation that the protein 
precipitate performed best, i.e. induced the lowest percent deposition, when it was 
crossed-over into the ultrafiltered urine of the other race group. Thus WPP produced 
the lowest percentage deposition in BUF (Figure 4.2.1) while BPP has its most 
marked effect in WUF (Figure 4.2.2). The data and plots for all of the experiments 
are shown in Appendix 1 (Black subjects: Tables C2.1 and Figure 82.1; White 
subjects Tables C2.2 and Figure 82.2). 
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Figure 4.2.1 
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Figure 4.2: A typical plot of percent C4C] - oxalate deposition in BUF 
(Figure 4.2.1) and WUF (Figure 4.2.2) urine before and after addition of 
protein precipitate from black (BPP) and white (WPP) subjects at final 
concentrations of 0.5 mg/L 
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Comments: 
These results demonstrate that protein precipitates, irrespective of the ethnic origin, 
are inhibitors of CaOx deposition and that urine composition affects their 
performance in this regard. Surprisingly, crossed-over combinations were the most 
effective. This is contrary to previous results for THP (Cra1g et a!. 2000) and UPTF1 
(V' ebber et at 2002) which showed a supportive synergistic relationship between the 
protein and its own urine. The results were unable to establish whether either of the 
protein precipitates was superior to the other. Nevertheless, the general principle 
that the urine milieu affects the inhibitory performance of urinary proteins is again 
apparent. 
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Effect of BPP and WPP on crystal aggregation 
In these experiments, the addition of BPP and WPP to a slurry of COM crystals 
induced a significant inhibition of aggregation. The percentage inhibition by BPP 
(range 81-94 %, mean 88 %) was not significantly different to that of induced by 
WPP (range 81-90 %, mean 83 %). Figure 4.3 shows a typical plot of the 
absorbance vs time of a COM slurry before and after addition of BPP and WPP. This 
figure demonstrates that the sedimentation rate is reduced by the addition of protein 
precipitate, irrespective of its origin. The plots for each experiment are shown in 
Appendix 2 (Black subjects: Figure C2.1, White subjects: Figure C2.2). 
Table 4.2: Gradients for the plots of absorbance vs time for COM crystal slurries 
before and after addition of BPP and WPP and corresponding inhibition of 
aggregation(% lA). 
Sample Absorbance slope %lA 
(x1o-ss-1) (R2) ± SE 
COM (n=5) -430 (0.993) ± 16.2 
COM+BPP1 -70.0 (0.957) 84 
COM+BPP2 -40.0 (0.964) 91 
COM+BPP3 -80.0 (0.994) 81 
COM+BPP4 -50.0 (0.965) 88 
COM+BPP5 -23.0 (0.884) 94 
Average -54.0 (0.998) ± 1 0.2 88 
COM+WPP1 -26.0 (0.982) 90 
COM+WPP2 -40.0 (0.955) 84 
COM+WPP3 -35.0 (0.752) 86 
COM+WPP4 -62.0 (0.983) 75 
COM+WPP5 -48.0 (0.890) 81 
Average -42.0 (0.912) ± 6.10 83 
81 
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Figure 4.3: A typical plot of absorbance vs time for the 
sedimentation of COM crystal slurry before and after addition of 
BPP and WPP at 0.5 mg/L. Arrows indicate the time at which the 
stirring was stopped to induce crystal aggregation 
Comments: 
The protein precipitate from both race groups significantly inhibited COM 
aggregation to a similar extent. Aggregation is a process of crystals adhering 
together to form a large mass and allows the formation of larger particles and at a 
faster rate (Kok et a/. 1993; 1994 ). Therefore the ability of BPP and WPP to retard 
this process highlights their protective role in kidney stone formation. 
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Effect of protein precipitate on crystal nucleation 
These experiments showed strong inhibition of CaOx crystal nucleation by both BPP 
(range 80-90 %, mean 85 %) and WPP (range 47-93 %, mean 76 %). However, 
these values were not significantly different. A typical plot of the absorbance vs time 
of a decrease is shown in Figure 4.4. The individual plots for these experiments are 
shown in Appendix 2 (Black subjects: Figure 02.1: white subjects: Figure 02.2). 
Table 4.3: Gradients for the plots of absorbance vs time of the control solution 
(CaCI2 + Na20x) before and after addition of BPP and WPP, and percentage 
inhibition of nucleation (% In) 
Sample Absorbance slope 
(x1 0"5s -1) (R2) 
%In 
Control (C) (n=5) 54.3 (0.989) ± 4.98 
C+BPP1 10.0 (0.959) 82 
C+BPP2 11.0 (0.950) 80 
C+BPP3 8.0 (0.957) 85 
C+BPP4 7.3 (0.886) 86 
C+BPP5 5.3 (0.990) 90 
Average 8.3 (0.948) ± 1.00 85 
C+WPP1 5.3 (0.986) 90 
C+WPP2 15.0 (0.901) 72 
C+WPP3 29.0 (0.765) 47 
C+WPP4 13.0 (0.890) 76 
C+WPP5 4.0 (0.992) 93 
Average 13.3 (0.908) ± 4.50 76 
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Figure 4.4: Plot of absorbance vs time for the 
nucleation assay before and after addition of BPP and 
WPP at 0.5 mg/L 
Comments: 
The results of these experiments have shown that urinary protein precipitates from 
both race groups are strong inhibitors of CaOx nucleation, and that there is no 
statistical difference between them in this regard . 
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Effect of BPP and WPP on particle formation kinetics 
Particle size distribution 
Bimodal particle size distributions were observed in two of five BUF samples, while a 
unimodal distribution were observed in four of five WUF samples. In general, there 
was a greater number of particles in WUF at baseline and these were of larger size 
(Figure 4.5). The latter figure shows the typical plot of the particle size distribution in 
ultrafiltered urine at 30 min intervals. In BUF, addition of BPP tended to produce 
smaller crystals but no clear evidence was evident when WPP was added (Table 
4.4). In WUF, neither BPP nor WPP produced identifiable trends (Table 4.4). The 
plots from individual subjects are shown in Appendix 2 (Black subjects: Figures E2.1, 
White subjects: Figures E2.2). 
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Table 4.4: Particle size (IJm) in ultrafiltered urine from black (BUF) and white (WUF) 
subjects before and after addition of BPP and WPP at final concentrations of 0.5 
mg/L 
BUF 
Experiment 1 ** 4.7 and 17.5 
Experiment 2 5.5 
Experiment 3 3.3 
Experiment 4 * 3.6 and 16.4 
Experiment 5 4.3 
WUF 
Experiment 1 ** 3.2 and 12.4 
Experiment 2 10.6 
Experiment 3** 7.3 
Experiment 4 * 8.0 
Experiment 5* 8.3 
* Trend showing a decrease 
**Trend showing an increase 
BUF+BPP BUF+WPP 
4.4 and 15.7 7.7 and 16.4 
4.7 5.8 
3.6 3.3 
3.3 and 14.5 3.3 and 14.9 
3.3 5.4 
WUF+WPP WUF+BPP 
3.6 and 17.5 3.3 and 16.8 
16.8 8.0 
9.5 10.6 
7.7 4.7 
4.4 5.1 
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Figure 4.5.1 
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Figure 4.5: Particle size distribution in ultrafiltered urine from 5 
black (Figure 4.5.1) and white males (Figure 4.5.2) before and 
after addition of BPP and WPP at final concentrations of 0.5 
mg/L 
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Comments: 
The observation of bimodal size distribution in BUF is somewhat surprising as it 
contradicts the general observation in the previous chapter that such distributions 
are rare. The importance of having many size distributions (as opposed to merely 
five) before drawing from conclusions is therefore apparent. The same point needs 
to be made for the other observed feature of the present set of distribution, namely 
that particle numbers and sizes were larger in WUF. While this is interesting as it is 
consistent with lower stone incidence in black subjects, the observation needs to be 
tested in a much larger series of particle number-size distribution. 
Regarding the effects of the protein precipitated on particle size, no obvious 
trend was observed for WPP. However, a tendency for BPP to reduce size was 
observed, albeit that the trend was not convincing. Nevertheless, the possibility that 
BPP acts as inhibitory of CaOx crystal growth is noted here. 
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Particle number 
In BUF, the general trend showed that particle number at 120 min decreased when 
protein precipitate was added to the test solution, irrespective of the protein 
precipitate's origin, although increases in particle number were also observed. A 
similar trend in WUF was not observed. Consistent reproducible differences 
between BPP and WPP were not evident. Typical plots of particle number vs. time 
are given in Table 4.6 while the data and plots for each of these experiments are 
shown in Appendix 2, Tables 8 (Black subjects: Tables 02.1 and Figures F2.1; 
White subjects: Tables 02.2 and Figure F2.2). 
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Figure 4.6.1 
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Figure 4.6: Typical kinetics plots for the particle formation in the 
ultrafiltered urine of black (Figure 4.6.1) and white subjects (Figure 
4.6.2) before and after addition of BPP and WPP at final 
concentrations of 0.5 mg/L 
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Comments: 
The data obtained in these experiments failed to show clearly defined trends, 
thereby highlighting again the difficulty of interpreting Coulter Counter data. The only 
trend which was weakly suggested was that protein precipitates may be inhibitors of 
CaOx crystal nucleation in BUF but not in WUF. This again draws attention to the 
influence that urine composition may have in directing crystallization processes. 
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Particle volume 
The general trend in these experiments showed a decrease in particle volume when 
both BPP and WPP were added to BUF and WUF. It was not obvious whether either 
of these produces a consistently greater effect. Typical plots are given in Figure 
4.7.1 and 4.7.2 and plots for each experiment are shown in Appendix 2, Tables 
(Black subjects: Table E2.1 and Figure G2.1; White subjects Table E2.2 and Figure 
G2.2). 
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Figure 4.7.1 
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Figure 4. 7: Plots of a typical graph of the particle volume in 
BUF (Figure 4.7.1) and WUF (Figure 4.7.2) before and after 
addition of BPP and WPP at final concentrations of 0.5 
mg/L at 30 min intervals. 
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Comments: 
The particle volume which showed a decreasing trend when BPP and WPP was 
added on either BUF or WUF is an indicating of a decrease in the total mass induced 
crystalline material. As explained earlier in Chapter 3, the final conclusion on the 
ability of BPP and WPP cannot be based on this experiment alone and therefore we 
can only speculated that these experiments indicate aggregation inhibition by the 
proteins included in the precipitate, irrespective of the race group from which it was 
derived. 
As explained in Chapter 3, a decrease in particle volume is most likely 
indicative of inhibition of nucleation or growth. Unlike the other Coulter data, trends 
for the particle volume were consistent and reproducible in both BUF and WUF, 
thereby allowing a more confident interpretation. These results therefore suggestion 
that the protein precipitates acts as inhibitors of nucleation and growth. 
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4.4 Discussion 
The results of the experiments describes in this chapter were disappointing because 
consistent, definitive trends were not detected, nor was it possible to identify 
differences in the behavior of the protein precipitates from the two race groups. 
Evidence suggesting that protein precipitates are inhibitors of CaOx crystal 
nucleation was compellingly provided by the C4C]-oxalate deposition and was weakly 
supported by the Coulter number and volume data. The sedimentation experiments 
also showed that the protein precipitates inhibit CaOx crystal aggregation. Weak 
evidence suggesting the possibility of growth, inhibition was provided by the Coulter 
size and volume data. The findings in this chapter are in agreement with previous 
studies which have shown that proteins precipitates from the urine inhibit CaOx 
nucleation, aggregation and growth (Boyce et at. 1968; Coe et at. 1991; Grover eta/. 
1998). 
95 
Chapter 5 
Isolation, purification and 
characterization of bikunin 
5.1 Introduction 
In the previous chapter, the results demonstrated that urinary protein precipitates have 
inhibitory properties with respect to CaOx crystallization. While these studies are of 
interest and help us speculate generally on the role of urinary protein inhibition in 
providing the South African black population with protection against CaOx urolithiasis, 
they do not allow us to draw any firm conclusion about individual proteins. In particular, 
it is not possible to deduce the role of bikunin, which is the protein selected for study in 
th is thesis. This chapter describes attempts to isolate, purify and characterize bikunin 
from the urine of both race groups so that their relative inhibitory capacities can be 
investigated. 
Bikunin isolated from human urine has been reported to have a concentration of 
6.25-18 nmoi/L (Dean eta/. 2003). The protein is composed of a 16 kDa polypeptide 
chain , a 7-8 kDa chondroitin sulphate side chain and an N-linked oligosaccharide of 
about 1-2 kDa (Medetognon-Benissan et a/. 1999; Yang et a/. 2005). Structural 
variations in the glycosaminoglycan moiety, the polysaccharide side chains and the 
amount of sulphation appear to result in the existence of several charged isoforms 
bikunin (Yuki eta/. 1993). 
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Objectives 
The objectives for this part of the study are as follows: 
•!• To prepare precipitates of COM and COD crystals from the urine of healthy black 
and white male subjects to test the presence of bikunin 
•!• To prepare the protein precipitate from the urine of both groups to test the 
presence of bikunin 
•!• To isolate and purify urinary bikunin from the protein precipitates using 
immunoaffinity chromatography 
•!• To characterize purified bikunin using the following techniques: 
1) SDS-PAGE 
2) Western blotting 
3) Matrix-assisted laser desorption/ionisation time-of-flight mass 
spectroscopy (MALO I-TOF MS) 
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5.2 Methods 
5.2.1 Precipitation of calcium oxalate monohydrate (COM) and 
dihydrate (COD) crystals from urine 
24 hr urine samples from five black and five white healthy male subjects were collected 
and tested for haematuria and infection using urinalysis test strips (Medi Test Combi 
5N, Macherey-Nagel). Urines testing positive for either were excluded. One liter of 
urine from each subject was then pooled according to race and filtered through a 
0. 75 1-1m pre-filter followed by a 0.45 1-1m nitrocellulose filter paper before use. 
The urine was heated to 37 °C in a shaking water bath at 100 rpm. The Ca2+ 
concentration was adjusted to 0.5 mM by dilution with distilled water (Hess 1989, 
Webber et a/. 2003) while it was adjusted to 12 mM (by addition of CaCb) to induce the 
formation of pure COD crystals (Webber et a/ 2003). After the adjustment of urinary 
calcium, the CaOx metastable limit (MSL) of each portion was measured and 
crystallization was induced by the dropwise addition of 10 % Na20x (v/v) at 30 1-1M 
above MSL. The dropwise addition of Na20x was repeated at 0, 1 and 2 hrs. The 
precipitated crystals were collected after a total incubation period of 3 hrs, filtered 
though 0.22 1-1m filter paper and thoroughly washed with distilled (XRD) water and dried 
at 95 °C for 1 hr. 
XRD 
X-ray powder diffraction was used to identify the hydrates which had formed. The 
interplanar d-spacings of the CaOx crystals were compared with the standard reference 
values for COM and COD (Table 5.1 ). The XRD patterns of the crystals together with 
the d-spacings (A) of prominent peaks correspond to those shown in Table 5.1. Figure 
5.1 shows plots of the x-ray powder diffraction patterns and the d-spacing of COM 
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Table 5.1: lnterplanar spacings and relative intensities of powder patterns of CaOx 
crystals 
*Standard d-spacing and relative intensity data Present Study 
d-spacing 
(A) 
5.93 
5.79 
4.64 
4.52 
3.7J-
3.7 
3.65 
3.00 
2.97 
2.91 
2.89 
2.84 
2.51 
2.48 
2.41 
2.37 
2.34 
COM 
Relative 
Intensity (I) 
100 
25 
7 
6 
13 
100 
10 
46 
12 
10 
14 
2 
30 
5 
2 
90 
*Sutor and Scheidt 1968 
COD COM COD 
d-spacing 
(A) 
Relative d-spacing d-spacing 
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Figure 5.1.1 
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Figure 5.1: x-ray powder diffraction patterns of COM 
(Figure 5.1.1) and COD (Figure 5.1.2) crystals 
Demineralization 
40 
The crystals were demineralized using 0.25 M EDTA (pH 8) (1 g/1 00 ml), dialyzed 
against distilled water and freeze-dried. This yielded a COM and COD crystal matrix. 
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5.2.2 Isolation of protein precipitate (PP) from urine 
Protein precipitates were isolated using ammonium sulphate from the 24 hr urine 
samples which were collected from five healthy black and five white subjects using the 
method described in Chapter 4.2.2, page 74. 
5.2.3 Protein concentration determination 
The protein concentrations of the COM, COD and protein precipitates were determined 
using the Bradford method described in Chapter 2.2.3, page 38. The assays were 
performed in duplicate. 
5.2.4 Bikunin isolation 
lmmunoaffinity chromatography 
Trypsin CNBr-sepharose affinity column chromatography has been used for the 
isolation of bikunin because of the proteins ability to bind to trypsin (Medetognon-
Bonissan eta/. 1999; Yang eta/. 2005). NP-HPLC has also been used (Hochstrasser 
et a/. 1984) to separate bikunin. In the present study, immunoaffinity chromatography 
method was selected for the isolation of bikunin because previous studies have shown 
that immunoaffinity chromatography is an efficient method (Sauer et ell 1 ~ Q ). 
The principle of immunoaffinity chromatography is based on the highly specific 
interaction of an antigen with its antibody. It is therefore a type of chromatography that 
allows for the separation of a particular protein. In the present study bikunin was 
separated from a solution containing many different proteins. The affinity material is 
made from a solid substance such as Protein G beads to which the substrate of the 
protein (i.e. antibody) is covalently attached. A specific antibody binds only to the 
desired protein, even from an extract containing thousands of different proteins. In this 
study a specific monoclonal anti-Microglobulin (alpha 1) antibody (Abeam, UK) was 
used to bind to the bikunin from the urinary protein precipitate. 
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Column preparation 
Protein G sepharose beads (0.25 g) were washed three times with 10 ml phosphate 
buffered saline (PBS, pH 7.5) and 14 mg of anti-Microglobulin (alpha 1) antibody was 
added. The protein G-antibody mixture was rotated overnight at 4 °C and washed three 
times with 10 ml PBS (pH 7.5). The antibody was cross-linked to the protein G using 20 
mM dimethylpimelimidate in 3 M NaCI and 50 mM borate, pH 9 by rotating for 1 hr at 
room temperature. Binding of the antibody to Protein G was assessed using the 
Bradford assay. The preparation was washed three times with 0.2 M ethanolamine, pH 
8 and resuspended in PBS. Glass wool was placed at the bottom of a 2.5 ml column 
and the Ab-protein G-Sepharose G slurry was transferred to the column. In order to test 
whether the antibody was cross-linked to protein G, the column was washed with 100 
mM glycine, pH 2.8 at a rate of 0.5 ml/min and the absorbance of the eluent was 
measured at 280 nm. 
Isolation of bikunin from the protein precipitate using immunoaffinity 
chromatography 
The principle of column chromatography procedure is depicted in Figure 5.2. The 
protein precipitates from black and white subjects were independently applied to the 
immunoaffinity column at a flow rate of 0.5 ml/min, the unbound material was collected. 
The column was washed overnight with PBS. The bound bikunin was eluted using 100 
mM glycine, pH 2 and the eluent was neutralized immediately by the addition of 1 M 
Tris, pH 9.5 to stabilize the pH. The column was preserved with 0.02% sodium azide in 
PBS. 
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Step 1: 
_j L 
------ ~=-----l ._ __ v ______ v ______ V_.._  ___.I Flow out Flow in 
Step 2: 
Protein precipitate 
Step 3: 
PBS, pH 7.5 
Step 4: 
100 mM glycine, pH 2 
V Antibody 
e Bikunin 
Protein precipitate 
Unbound proteins 
To detector 
Pure bikunin 
Figure 5.2: lmmunoffinity column chromatography. Step 1: before sample 
loading. Step 2: loading of the protein precipitate and collection of the 
unbound proteins. Step 3: column wash with PBS. Step 4: elution of bound 
bikunin. Figure modified from http://tamuk.ed/fpllc/ pursamat/html 
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5.2.5 Characterization of protein extraction 
SDS-PAGE 
Proteins extracted from the urine of both population groups were analysed by 10 % 
SDS-PAGE using the method described in Chapter 2.2.3, page 39. A low range 
molecular weight marker was included (Bio-Rad). The samples were run under 
reducing and non reducing conditions (i.e. with and without mercaptoethanol). The gel 
was developed using a Coomassie Blue or silver staining procedure as described in 
Appendix 2.1. 
Western blot 
The SDS polyacrylamide gel and a nitrocellulose membrane were equilibrated in a 
blotting buffer (method in Appendix 1.1) for 15 min. The proteins from the gel were 
transferred to the nitrocellulose membrane at 300 rnA for 1 hr with cooling. Non-specific 
binding sites on the membrane were blocked overnight with agitation using blocking 
buffer (Appendix 1.1 ). The membrane was incubated for 1 hr in the monoclonal anti-
Microglobulin (alpha 1) which was diluted 1:1000 in blocking buffer. The blot was 
washed extensively with the same buffer and then incubated for 1 hr in anti-sheep lgG 
which was diluted 1:1000 in blocking buffer and incubated for an hour. After exposure 
to both antibodies, the blot was washed extensively with blocking buffer and the HRP 
(horse radish peroxidase) conjugate was detected using detection with a solution 
containing 4-chloro-1-napthol (Sigma) (Appendix 2.1 ) for approximately 15 min in a 
dark room. 
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Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-TOF) 
mass spectrometry 
Molecular weight determinations were performed on the purified bikunin isolated from 
both black and white subjects using MALO I-TOF MS (Perseptive Biosystems Voyager 
DE-PRO, USA) according to methods described by Egelhofer et a/. 2002. Briefly, the 
proteins were separated on SDS-PAGE and the bands were excised and soaked in 50 
~L acetonitrile and 25 mM NH4HC03 for 15 min. The supernatant was discarded and 
the gel was soaked again for further 10 min in 50 ~L 25 mM NH4HC03. The bands were 
dried in a speedivac for 30 min and trypisin digested. The trypsin digestion method 
involves swelling of the gel pieces with 12.5 ng/~L trypsin (Promega) in 50 mM 
NH4HC03 on ice. 10 ~L of this solution was added initially followed by the addition of 
small amounts (1-2 ~L) so that the gel fully rehydrates without leaving excess of trypsin 
solution. To keep the gel wet, the sample was covered with a minimum volume of 50 
mM NH4HC03 and incubated at 37 °C for 4 hrs. For the MALDI analysis 1 ~L of the 
above sample was mixed with 1 ~L MALDI-TOF MS matrix. The matrix was a saturated 
solution of 3,5-dimethoxy-4-hydroxycinnamic acid (Sinapinic acid) in 50 % acetonitrile 
and 0.3 % TFA. The mixture (2 ~L) was applied to a MALDI P100 gold sample plate 
and allowed to dry by gentle streaming with air to allow crystallization of the matrix and 
the sample. The sample was then analyzed 
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5.3 Results 
5.3.1 Characterization of urinary protein extraction 
Protein concentration 
The table below presents the average protein concentration values of COM from three 
separate urine pools, COD from one pooled urine and PP from five pools of urine. The 
average total protein concentration of the PP was determined to be 20 and 16 mg/L for 
samples from black and white samples, respectively (Table 5.2). Owing to the fact that 
protein precipitation using 80 % ammonium sulphate saturation gave higher total protein 
yields than those obtained in the crystals matrices, PP was selected for further bikunin 
isolation. 
Table 5.2: Total concentration of proteins in CaOx crystal matrices and protein 
precipitates 
Black subjects White subjects 
(mg/L) (mg/L) 
COM (n=3, pools) 10.8 11.6 
COD (n=1 , pools) 14.5 15.8 
PP (n=5, pools) 20.0 16.0 
106 
C h a p t e r F1ve 
SDS-PAGE and Western blotting 
Figure 5.3 shows SDS-PAGE and Western blot of the protein precipitate isolated from 
the urine of black subjects and white subjects respectively. Bands ranging from 20-120 
kDa were observed in the protein precipitates, irrespective of the race group from which 
they were derived. A band at 30 kDa corresponding to bikunin was observed on the 
Western blot, under both reducing and non-reducing conditions. Since the blot for both 
black and white subjects were qualitatively similar, only one gel and blot are presented. 
Figure 5.3: SDS-PAGE (Figure 5.3.1) and Western blot (Figure 5.3.2) of protein 
precipitate isolated from the urine 
pp M kDa 
.,_120 
.-97 
.-so 
.-60 
• 45 
.-30 
.-20 
Figure 5.3.1: Protein precipitate (PP) 
isolated from the urine 
kDa 
120---. 
97-+ 
66---+ 
30-+ 
M R NR 
Figure 5.3.2: Western blot of the Protein 
precipitate immunoblotted for bikunin. 
Lane M-marker, R-reduced conditions 
and NR-non- reduced conditions 
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Figures 5.4 and 5.5 show the SDS-PAGE and Western blot of COM and COD crystal 
matrix extracts obtained from the urine of black and white subjects, respectively. SDS-
PAGE run under reducing conditions showed several protein bands in the range 30 -
120 kDa for both COM and COD crystals. 2 mg of protein was loaded on each lane for 
both Band W for both SDS-PAGE and Western blot. The bands observed were similar 
for both race groups. A 30 kDa band corresponding to bikunin was observed in both 
race groups' COM and COD crystals by immunoblotting. 
Figure 5.4: SDS-PAGE (Figure 5.4.1) and Western blot (Figure 5.4.2) of COM crystals 
isolated from black and white subjects 
w M 
120 
97 
66 
45 
30 
20 
B 
Figure 5.4.1: SDS-PAGE of COM 
crystals isolated from black (B) and 
white 0N) subjects; M: low molecular 
weight marker. 
w B 
+- 30kDa 
Figure 5.4.2: Western blot of COM 
crystals isolated from black (B) and 
white 0N) subjects immunoblotted for 
bikunin. 
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Figure 5.5: SDS-PAGE (Figure 5.5.1) and Western blot (Figure 5.5.2) of COD crystals 
isolated from black and white subjects 
8 w M kDa 
._97 
._66 
._45 
._30 
Figure 5.5.1: SDS-PAGE of the COD 
isolated from black (B) and white (W) 
subjects; M: low molecular weight 
marker. 
Comments: 
8 w 
.._ 30 kDa 
Figure 5.15.2: Western blot of COD 
crystals isolated from black (B) and 
white (W) subjects immunobloted for 
bikunin. 
The initial step in an attempt to purify bikunin involved the determination of the protein 
concentration of the proteins precipitated from the urines of black and white male 
subjects prepared using three different protein precipitation methods. These methods 
included the preparation of COM and COD crystals by adjusting the calcium 
concentration in the urine to 0.5 and 12 mM respectively, and the preparation of a 
protein precipitate using 80 % ammonium sulphate saturation. The protocol which 
produced best yields was selected for further bikunin isolation, namely protein 
precipitate. Western blotting confirmed the presence of bikunin in all of the protein 
precipitates isolated from the urines of both black and white male subjects, as shown by 
a broad band at 30 kDa. 
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5.3.2 Bikunin purification 
Bikunin was purified from the protein precipitate using immunoaffinity chromatography. 
Three fractions were collected as shown in Figure 5.6. The first fraction (a) 
corresponded to the unbound proteins and was collected after the first absorbance 
increase. The column was washed extensively with a PBS buffer and this fraction (b) 
was collected. The bound bikunin fraction was then eluted as single peak (c) using 
glycine (pH 2.8). 
0 
CX) 
N 
0 
0 
'----------'-- ------'---_.../ '-~---- -c--) '~-...... =-----.1 
---v-a Yb vc 
Time (min) 
Figure 5.6: Elution profile for bikunin purification using immunoaffinity 
chromatography 
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Table 5.3 shows the bikunin concentration obtained from each batch of protein 
precipitate subjected to immunoaffinity chromatography. The protein concentration 
ranged between 0.36-0.64 mg/L and 0.11-0.70 mg/L for black and white subjects, 
respectively. Comparison of the mean concentration of bikunin in the two race groups 
did not reveal any significant differences. 
Table 5.3: 8ikunin concentration (mg/L) of urine from black (88) and white (W8) 
subjects' urine 
Batch Bikunin Batch Bikunin 
concentration concentration 
(mg/L) (mg/L) 
881 0.40 W81 0.48 
882 0.64 W82 0.40 
883 0.36 W83 0.70 
884 0.44 W84 0.25 
885 0.48 W85 0.11 
Average± SE 0.46 ± 0.079 Average± SE 0.32 ± 0.079 
SDS-PAGE and Western blotting 
Figure 5.7 shows the SDS-PAGE and Western blot of the bikunin isolated from the urine 
of black and white subjects using immunoaffinity chromatography. Under reducing 
conditions two bands at 30 and 60 kDa were observed. The isolated bikunin produced 
three major bands on SDS-PAGE at 120, 97 and 60 kDa (Figure 5.7.1). In order to 
confirm that the bands on the silver stained gels were due to bikunin, equivalent protein 
loads were immunoblotted for bikunin (Figure 5. 7.2). The major bands on the gel also 
appeared on the Western blot. The band at 60 kDa as indicated by the arrow was faint. 
Since the blot for both black and white subjects were qualitatively similar, only one gel 
and blot is presented. 
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Figure 5.7: SDS-PAGE and Western blot of purified bikunin 
kDa M 
120 
97 
60 
45 
20 
pp R NR 
Figure 5.7.1: SDS-PAGE of the protein 
eluent; Lane NR- non reduced, lane R, 
reduced, lane PP- protein precipitate 
before column, M: low molecular weight 
marker. 
kDa 
12( 
97 
66 
30 
20 
M pp R NR 
Figure 5.7.2: Western blot; before 
column protein precipitate was 
loaded on the column lane (lane PP), 
protein eluent, from left lane NR 
(non-reduced) lane R (reduced) 
immunoblotted for bikunin. 
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Table 5.4: MALO I-TOF MS analysis of tryptic bikunin peptides from black (BB) and 
white (WB) subjects 
Peptide residue Theoretical Observed m/z 
mlz BB BB WB WB 
No. Band 1 Band 2 Band 1 Band 2 
22-41* 2264.6** 2262.43 
23-41 2136.5** 2135.36 
71-92* 2547.1** 2545.22 
78-88 1228.5** 1225.60 
78-92* 1570.9 1568.74 
89-104* 1894.2** 1898.46 
93-104 1409.7 1411.04 
93-121 * 3204.7** 3205.45 
107-121 1699.9** 1697.90 
107-126* 2354.7** 2351.83 
107-129* 2600.9 2602.13 2601.27 
122-126 673.7 672.4 672.90 670.1 
130-147* 2001.1 1999.20 
* Peptides resulting from incomplete trypsin cleavage. 
**These peptides formed acrylamide adducts due to the presence of cysteine residues. The observed 
masses of these peptides increased by 71.1 kDa for every cysteine residue that was modified 
AVLPQEEEGSGGGQLVTEVTKKEDSCQLGYSAGPCMGMTSRYFYNGTSMACETFQYGG 
1 10 45 58 
CMGNGNNFVTEKECLQTCRTV AACNLPIVRGPCRAFIQLWAFDAVKGKCVLFPYGGCQGN 
59 118 
GNKFYSEKECREYCGVPGDGDEELLRFSN 
119 147 
Key: BB (band 1 ), BB2 (band 2), WB1 (band 1 ), WB2 (band 2) 
Figure 5.9: Bikunin sequence and amino acid coverage of BB and WB 
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The coloured lines indicated on the bikunin sequence above (Figure 5.9) show the 
coverage of the amino acids of each bikunin band analyzed by MALO I-TOF MS. Except 
for WB (band 1 ), which showed small amino acid coverage, BB (bands 1 and 2) and 
WB (band 2) demonstrated a large range of amino acid coverage. As depicted in 
Figure 5.1 0, bikunin has an O-lin ked glycan attached to the serine residue at position 10 
and an N-linked glycan attachment to the asparagine at position 45 of the core protein. 
This glycosylation hindered the mass determination of theN-terminal peptide (1-21) and 
peptide (42-70) as the exact masses of these peptides are not known (highlighted in 
bold in Figure 5.9) . 
' ~ 
• 
-<l <I 
• • 
Figure 5.10: Structure of N-linked and O-lin ked glycans 
present on bikunin (Balduyck at a/. 1986) 
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5.4 Discussion 
This chapter focused on the description of the isolation of bikunin using immunoaffinity 
chromatography, a method chosen because it has been shown in previous studies to be 
efficient for protein isolation (Sal1er et a/ 1983). lmmunoaffinity chromatography was 
used successfully to isolate bikunin from the protein precipitate obtained from the urines 
of black and white male subjects. The 30 kDa mass seen on SDS-PAGE agrees with 
the mass reported for bikunin (Enghild et a/. 1989; Morikawa et a/. 1994; SuLuk1 e' a/ 
2 01, Okuyamd et at. 2003) and the 60 kDa has also been reported previously 
(Muramatsu eta/. 1980; Pat . r~/ 198 Slota eta/ 1994; S lZU A a1 2. 01 ). The 
mass at 60 kDa might be due to increased glycosylation and sulphation or variations in 
the glycosaminoglycans and polysaccharide side-chain ( a et at 2005). Another 
possibility is that bikunin could exist as a dimer which has been reported in numerous 
studies (Muramatsu et a/. 1980; ~ att L ..... " Slota et a/. 1994; S /U 1 Ar ~I 2001 ). 
Both bands on SDS-PAGE were confirmed to be bikunin by Western blotting (Figure 
5.7, page 112) and MALDI-TOF MS (Table 5.4). The higher masses observed under 
non-reducing conditions are in agreement with those which has been previously 
reported. For example, Marengo et a/. (1998) stated that the use of non-reducing 
conditions combined with increased exposure times during the development of gels and 
blots yields higher molecular weight dimer/ trimer forms of bikunin. 
Of further interest was the yield of the bikunin eluted from the column. An 
average of 0.46 and 0.32 mg/L was obtained for bikunin isolated from the urine of black 
and white subjects, respectively. This concentration is within the published estimates of 
bikunin concentration in human urine (Nishi no eta/. 1989; Suzuki eta/. 2001 ). Although 
bikunin excretion appears to be higher in black subjects, the difference is not significant. 
Bikunin is a "sticky protein" (Suzuki et :7/ 2001 ) and it is likely that a significant amount 
of it was lost in the isolation process due to it sticking on the surface of the walls of any 
apparatus used. The protein was considered to be pure since all bands observed on the 
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SDS-PAGE reacted with a monoclonal antibody and showed MALDI-TOF MS peaks 
corresponding to those reported for bikunin. Structural differences were observed in the 
bikunin isolated from the two race groups, for example bikunin isolated from black 
subjects showed a larger coverage of bikunin amino acids. Since some of the amino 
acids which easily bind calcium have been reported to play a role in the inhibitory 
activity of the proteins on CaOx crystallization (Franzen and Heinegard 1985; Chen et 
at. 1992; Denhardt and Guo 1993; Hunter et at. 1996), a larger coverage of amino acid 
by bikunin isolated from the black subjects suggest that bikunin might be a contributing 
factor in protecting the black South African population from the kidney stone disease. 
Although this is of major interest, further experiments are required to study the structure 
of bikunin isolated from black and white South African subjects. 
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Crystallization studies of purified 
bikunin in urine and inorganic solution 
6.1 Introduction 
As described in section 1.7 of this thesis, several in vitro crystallization studies have 
demonstrated that bikunin is an inhibitor of CaOx crystallization (Nakagawa et a/. 
1985; Hochstrasser eta/. 1984; Sorensen eta/. 1990; Atmani eta/. 1993a; Atmani et 
a/. 1993b; Atmani et a/. 1995) and, more specifically, that it modulates all three 
crystallization mechanisms, namely nucleation (Atmani et a/.1999; Hochstrasser et 
a/. 1984; Okuyama et a/. 1999; Atmani et a/. 1999); growth (Atmani et a/. 1993a; 
Atmani et a/. 1993b; Atmani et a/. 1999; Okuyama et a/. 2003) and aggregation 
(Atmani et a/. 1999). Moreover, the observation that urinary concentrations of 
bikunin in SF are lower than those in healthy controls, has prompted speculations 
that this could be a contributing factor in CaOx stone pathogenesis (Medetognon-
Benissan eta/. 1999). 
In the previous chapter, successful attempts to isolate bikunin from the urine 
of black and white South African subjects were described, albeit in smaller 
concentrations. The isolation of this protein from both race groups forms part of the 
rationale and strategy of this project and affords the opportunity to test the 
hypothesis that the protein derived from the urines of black subjects may be a more 
potent inhibitor of CaOx crystallization than that derived from white subjects. This 
chapter describes experiments which address this prospect. 
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Objectives 
The objectives of this particular study were to conduct a variety of crystallization 
experiments (as described in Chapter 2) to test and compare the relative inhibitory 
activity of the bikunin protein isolated from the urine of healthy black and white male 
subjects and to examine how this activity might be influenced by the urine 
environment in which it operates. 
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6.2 Methods 
6.2.1 Crystallization experiments 
Urine collection and treatment 
Single 24 hr urines were collected from each of five black and five white males and 
were treated using the method described in Chapter 2.2.1 , page 30. All the 
crystallization experiments were all conducted at a final protein concentration of 0.5 
mg/L. 
Effect of bikunin on {'4C]-oxalate deposition kinetics 
The effect of bikunin on C4C]-oxalate deposition was determined as described in 
Chapter 2.2.2, page 32. 
Effect of bikunin on crystal aggregation 
The effect of bikunin on crystal aggregation was determined using the method 
described in Chapter 2.2.2, page 35. 
Effect of bikunin on crystal nucleation 
Nucleation inhibition by bikunin was tested using the method described in Chapter 
2.2.2, page 36. 
Effect of bikunin on particle formation kinetics 
The particle formation (particle size, particle number and particle volume) 
experiments were conducted using the same protocol as that described in Chapter 
2.2.2, page 37. SEM was also determined as described in Chapter 2.2.2, page 37. 
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6.3 Results 
6.3.1 Effect of bikunin on [14C]-oxalate deposition 
These results demonstrate that addition of bikunin obtained from black (BB) and 
white (WB) subjects' urine reduced the percentage of C4C]-oxalate deposition in both 
BUF and WUF as shown in Figure 6.1 . The greatest decrease was observed in the 
crossed-over experiments i.e. in those experiments in which the protein from the one 
race group was tested in the ultrafiltered urine of the other race group. The typical 
figures show that gradients were the same in WUF, but that they decreased as 
protein was added in BUF. This suggests inhibition of the CaOx deposition rate by 
BB and WB in BUF. Data and plots for each of the five experiments is shown in 
Appendix 3 (Black subjects: Table C3.1: and Figure 83.1 ; White subjects: Table 
C3.2: Figure 83.2). 
121 
.!l 60 
ca 
c; 50 
>< 
Cjl 
u 40 
'ot 
... 
-
"C 30 
Cl) 
-.fl 
·- 20 Q. 
"(j 
!!! 10 
D.. 
~ 0 0 
50 ~ 45 
= 40 i 35 ? 30 
-
"C 25 
0 
! 20 
·a. 15 
-~ 10 -
... 
D.. 5 
30 
Chapter Six 
Figure 6.1.1 
60 
Time (min) 
Figure 6.1.2 
y = 0.40x + 6.8, R2 = 0.91 
y = 0.30x - 0.2, R2 = 0 987 
-.- BUF 
--- BUF+BB 
90 120 ---.....- BUF+WB 
= 0.29x + 9.8, R2 = 0.75 
~~~::=•y = 0.29x + 7, R2 = 0.855 
y = 0.27x + 1.8, R2 = 0.919 
-.-WUF 
---wUF+WB 
-;;e 0 (t"=----,-------,-------.--------, ---.....- WUF+BB 
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Time (min) 
90 120 
Figure 6.1: Typical plot of [14C]-oxalate deposition experiment 
expressed as percentage precipitated 
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Comments: 
These results have provided convincing evidence that bikunin reduces CaOx 
deposition irrespective of the race group from which it was derived. This suggests 
that bikunin is a strong inhibitor of CaOx crystal formation. Consistent reproducible 
differences were not observed between the two race groups. Interestingly, the 
magnitude of the effect of BB and WB in the CaOx deposition rate was greater in 
BUF. This suggests superior effect of the protein in the urine of the black subjects 
than in white subjects. As was also observed in Chapter 4, the cross-over 
combinations were the most effective in this experiment since they induced the 
lowest percent CaOx deposition. 
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6.3.2 Effect of bikunin on crystal aggregation 
Addition of 88 and WB in the COM crystal slurry induced an inhibition of crystal 
aggregation (Table 6.1) . The percentage inhibitions by 88 (range of 36-88 %, mean 
70 %) and WB (range of 46-91 %, mean 75 %) were not statistically significant. 
Figure 6.2 shows a typical plot of absorbance vs time of COM crystal slurry before 
and after addition of 88 and WB. The sedimentation rate of the COM slurry 
decreased greatly after addition of 88 and WB as demonstrated by this figure. The 
plots for each experiment are shown in Appendix 3 (Black subjects: Figure C3.1 ; 
White subjects: Figure C3.2). 
Table 6.1 : Absorbance slopes of COM crystal slurries before and after addition of 
8 8 and inhibition of aggregation (% lA) 
Sample Absorbance slope %lA 
(x10-5s-1) (R2) ± SE 
COM (n=5) -370 (0.978) ± 15.2 
COM+BB1 -150 (0.970) 55 
COM+BB2 -130 (0.878) 61 
COM+BB3 -60 (0.924) 82 
COM+BB4 -58 (0.943) 83 
COM+BB5 -40 (0.931) 88 
COM+BB6 -59 (0.980) 83 
COM+BB7 -107 (0.869) 68 
COM+BB8 -81 (0.9811 76 
COM+BB9 -211 (0.914) 36 
Average -100 (0.932) ± 18.6 70 
COM (n=5) -333 (0.962) ± 15.8 
COM+WB1 -30 (0.801) 91 
COM+WB2 -180 (0.889) 46 
COM+WB3 -106 (0.919) 68 
COM+WB4 -70 (0.982) 79 
COM+WB5 -30 (0.979) 91 
COM+WB6 -96 (0.958) 71 
COM+WB7 -78(0.968) 77 
COM+WB8 -151 (0.908) 55 
COM+WB9 -45 (0.985) 86 
COM+WB10 -62 (0.989) 81 
Average -85 (0.938) ± 15.7 75 
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Figure 6.2: A typical plot of absorbance vs time for COM 
slurry before and after addition of 88 and W8 at a final 
concentration of 0.5 mg/L. The arrow indicates the times at 
which the stirring was stopped to induce aggregation. 
Comments: 
CaOx crystal aggregation was strongly inhibited by addition of 88 and W8. Since 
this mechanism of crystal formation is a very important one in the formation of CaOx 
renal stones (Kok et a/. 1993), it can be concluded that bikunin from both black and 
white subjects plays an important role in retarding stone formation. However, the 
results of this particular experiment were unable to establish whether either of the 
proteins (i.e. 88 or W8) is superior to the other in this context. 
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6.3.3 Effect of bikunin on CaOx nucleation 
These results demonstrated that the percent inhibition of CaOx crystal nucleation 
observed after addition of 88 (range 20-60 %, mean 30 %) and WB (range 10-60%, 
mean 32 %) was not strong (i.e. only -30%), nor was there a statistically significant 
difference between 88 and WB. The values for each experiment are given in Table 
6.2 and a typical plot of absorbance vs time of the control before and after addition of 
88 and WB is shown in Figure 6.3. The plots for each experiment are shown in 
Appendix 3 (Black subjects: Figure 03.1; White subjects: Figure 03.2). 
Table 6.2: Absorbance slopes before and after addition of 88 and WB and inhibition 
of nucleation (% In) 
Sample Absorbance slope %In 
(x1o-ss-1) (R2) ± SE 
Control (C) (n=5) 50 (0.869) ± 5.00 
C+BB1 40 (0.961) 20 
C+BB2 30 (0.994) 40 
C+BB3 40 (0.966) 20 
C+BB4 40(0.815) 20 
C+BB5 40 (0.956) 20 
C+BB6 20 (0.956) 60 
Average 40 ( 0.941) ± 3.41 30 
C+WB1 30 (0.969) 40 
C+WB2 40 (0.876) 20 
C+WB3 30(0.951) 40 
C+WB4 20 (0.986) 60 
C+WB5 45 (0.968) 10 
C+WB6 40 (0.996) 20 
Average 38 (0.957) ± 5.23 32 
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Figure 6.3: A typical plot of absorbance vs time for the 
control before and after addition of 88 and W8 at a final 
concentration of 0.5 mg/l. 
Nucleation, a process that is defined as the appearance of detectable crystals 
(r-. a • a d K an 1999) was not strongly inhibited by the addition of 88 and W8, 
nor was there a difference between the proteins from the two race groups. Thus, it 
can be concluded that while inhibition of CaOx nucleation may indeed be an 
important process in differentiating between the stone forming potential in the two 
race groups, urinary bikunin does not play a role in this regard . 
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6.3.4 Effect of bikunin on particle formation kinetics 
Particle size distribution 
In these experiments a size reduction as indicated by a distribution shift to smaller 
values was observed when BB and WB were added to BUF in three of five 
experiments (Table 6.3). Unlike BUF, WUF demonstrated a bimodal size distribution 
(Table 6.3). These modes were observed in three of five experiments. A decrease 
in the size of the smaller crystals was observed in four of five WUF experiments 
when BB and WB were added. Of the three experiments that showed a bimodal 
distribution in WUF, the larger particles demonstrated a decrease when WB was 
added. The plots for each of the five experiments are shown in Appendix 3 (Black 
subjects: Figures E3.1; White subjects: Figures E3.2). 
Table 6.3: Particle size (~m) of ultrafiltered urine from black (BUF) and white (WUF) 
subjects before and after addition of BB and WB at final concentrations of 0.5 mg/L 
BUF BUF+BB BUF+WB 
Experiment 1 2.9 2.9 2.9 
Experiment 2* 5.8 2.9 2.9 
Experiment 3 6.9 8.7 6.9 
Experiment 4 * 5.4 4.4 3.5 
Experiment 5* 8.0 5.5 7.0 
WUF WUF+WB WUF+BB 
Experiment 1 5.8 and 15.3 2.9 and 13.11 4.4 and 15.6 
Experiment 2* 19.3 14.9 15.3 
Experiment 3* 17.5 16.0 16.4 
Experiment 4 3.6 and 7.7 6.5 and 12.0 7.2 and 12.0 
Experiment 5* 6.9 and 15.6 4.0 and 11 .3 4.0 and 15.3 
* Trends showing a decrease 
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Figure 6.4.1 
0 5 10 15 20 25 
Size (IJm) 
Figure 6.4.2 
a.. O.OOE+OO +---,.----,----,------,-----........,. 
0 5 10 15 20 25 
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BUF+WB 
-+-WUF 
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Figure 6.4: Particle size distribution in 8UF (Figure 6.4.1) 
and WUF (Figure 6.4.2) before and after addition of 88 
and W8. 
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Comments: 
Interesting findings emerged from these studies. For example, the particle size 
decreased when bikunin was added in both BUF and WUF. This suggests that 
bikunin isolated from the urine of black and white subjects inhibits CaOx growth. The 
observation that the particles in white subjects are larger and have bimodal 
distribution is not surprising and confirms a similar observation in Chapters 3. This is 
an unfavourable condition since larger particles form due to reduced or promotion of 
crystal aggregation (Hess et a/. 1996) and this is synonymous with the high 
occurrence of the stones reported in the South African population. 
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SEM 
The CaOx crystals precipitated after addition of Na20x were viewed using SEM to 
identify their morphology and extent of aggregation. Figure 6.5 shows the 
micrographs of CaOx crystals deposited after addition of NazOx before and after 
addition of 88 and W8. As shown in Figure 6.5.1, the crystals deposited in the 8UF 
have a predominantly COM crystal morphology while a mixture of COM and COD 
crystal morphology was observed in WUF (Figure 6.5.4). The crystal number 
decreased after addition of 88 in 8UF (Figure 6.5.2) and aggregates of crystals were 
seen after addition of W8 (Figure 6.5.3). Of further interest was that the morphology 
of the crystals changed from COM to COD when both 88 and W8 were added 
(Figure 6.5.2, 6.5.3, 6.5.5 and 6.5.6). Changes in sizes after addition of 88 and W8 
were not observed. The crystals were all viewed at 4K magnification except for 
Figure 6.5.6 which was viewed at 2.5K. This micrograph (Figure 6.5.6) is included to 
demonstrate morphology only. 
Figure 6.5.3: BUF+WB 
Figure 6.5: Scanning electron micrographs of CaOx crystals precipitated from 8UF 
(Figure 6.5.1, mag. 4K) before and after addition of 88 (Figure 6.5.2, mag. 4K) and 
W8 (Figure 6.5.3, mag. 4K), and addition that of WUF (Fugure 6.5.4, mag. 4K) 
before and after addition of W8 (Figure 6.5.5, mag. 4K) and after addition of BB 
(Figure 6.5.6 mag. 2.5K) at a final concentration of 0.5 mg/L 
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Comments: 
As stated in other chapters, the Coulter Counter has limitations and therefore SEM 
was used to supplement the experiments involving this instrument. The SEM 
demonstrated that addition of WB unfavourably formed aggregates of crystals in 
BUF. In vitro CaOx crystallization under the conditions employed in the present 
study produced predominantly COM crystals in the ultrafiltered urine from black and 
white subjects. The morphology of the crystals changed from COM to COD after 
addition of BB and WB in both BUF and WUF. Since it has been reported that 
bikunin prevents adhesion of calcium crystal to renal tubular cells in human urine by 
blocking the binding of C4C]-COM crystals to renal ephithelial cells (Cb1suno et at. 
1 ~99 a g e - 2005), it is possible that it achieves this by changing their 
morphology to COD crystals, which has been reported to be less adherent to renal 
tubular cells ( esso•, • I 1 898). This conversion may be regarded as favourable 
for another reason, namely that the higher positive charge on COD (due to greater 
number of calciums per unit cell) results in greater repulsive forces between crystals 
and therefore favors disaggregation (Webber 2003). 
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Particle number 
An obvious trend was observed in the particle number determinations when bikunin 
was added to BUF. For example, a decrease in particle number (90-120 min) was 
observed in these experiments when both 88 and WB were added. A consistent 
trend was not observed when bikunin was added to WUF, hence a typical plot for 
these experiments is not shown. Although the WUF experiment did not demonstrate 
any consistency, the plots for these experiments are shown in Appendix 3. Figure 
6.6 shows a typical plot for particle number experiment of BUF before and after 
addition of 88 and WB at 30 min intervals for 120 min. The rate of particle formation 
decreased on both BUF and WUF after addition of both 88 and WB as shown in 
Figure 6.6. The tables and plots for each experiment for each pool at 30 min interval 
are shown in Appendix 3 (Black subjects: Tables 03.1 and Figures F3.1; White 
subjects: Tables 03.2 and Figures F3.2). 
40000 
~ 35000 
g 30000 
~ 25000 
e 2oooo 
~ 15000 
Q) 
u 10000 
~ 5000 
Figure 6.6.1 
0 +-----~------~------~------
0 30 60 
Time (min) 
90 120 
--+- BUF 
--- BUF+BB 
___.....__ BUF+WB 
Figure 6.6: A typical plot of particle number of ultrafiltered 
urine from black subjects (6.6.1) 
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Comments: 
Particle numbers tended to decrease after addition of 88 in 8UF but addition of 
bikunin in WUF did not show any obvious trend. As with the other experiments 
presented in Chapters 3 and 4, this type of trend is interpreted as either inhibition of 
nucleation or aggregation promotion. The latter process (viz promotion of 
aggregation) can be ruled out on the basis of the sedimentation experiments 
described in section 6.3.2 which demonstrated inhibition of this mechanism. Thus, 
the decrease in particle number after addition of bikunin is indicative of nucleation 
inhibition. This is consistent with the results observed in the experiments described 
in section 6.3.3 which demonstrated a weak inhibitory effect towards nucleation. 
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Particle volume 
The particle volume determination demonstrated an increase in the particle volume 
when BB and WB were added to BUF and WUF. There were not significant 
differences observed between the two race groups (p>0.05). Figure 6.7 shows a 
typical plot of particle volume of ultrafiltered urine from BUF and WUF before and 
after addition of BB and WB at 30 min intervals for 120 min. The data and plots for 
experiments for each pool are shown in Appendix 3 (Black subjects: Tables E3.1 and 
Figures G3.1; White subjects: Tables E3.2 and Figures G3.2). 
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Figure 6.7.1 
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Figure 6.7.2 
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Figure 6.7: Typical plot of particle volume (1Jm3/5001JL) of BUF 
(Figure 6.7.1) and WUF (Figure 6.7.2) 
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Comments: 
An increase in particle volume could mean an increase in the total mass of deposited 
crystalline material due to crystal nucleation or growth. Alternatively, it could be due 
to imperfect packing together of crystals causing pores containing fluid thereby 
generating larger volumes. However, none of these processes is consistent with the 
results of other crystallization experiments in this particular study. 
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6.4 Discussion 
Following the successful isolation of bikunin, crystallization experiments were 
conducted to test the inhibitory activity of bikunin isolated from black and white South 
African male subjects. In the present study, two independent techniques (nucleation 
experiment and Coulter data) indicated that bikunin is an inhibitor of nucleation, 
albeit rather weak. This is in agreement with other reports which found bikunin to be 
an inhibitor of CaOx nucleation (Atmani et a/.1998; Medetognon-Benissan et a/. 
1999). Further support for this notion was provided by the C4C]-oxalate deposition 
experiments which demonstrated that bikunin is an inhibitor of CaOx crystal 
formation . 
Coulter data also showed that addition of bikunin inhibited CaOx crystal 
growth. Growth in the context of crystallization is usually taken to mean the 
enlargement of crystals by direct incorporation of solution species in to the solid 
crystal lattice. The observation that bikunin inhibits CaOx growth is in agreement with 
the literature reports (Atmani et a/. 1993; Okuyama et a/. 2003). The present study 
also demonstrated that bikunin is a strong inhibitor of CaOx aggregation and this is 
also in agreement with other reports in the literature (Atmani eta/. 1999). 
Interesting findings also emerged from this chapter as it was suggested that 
the mechanism by which bikunin is able to reduce the risk of kidney stone formation 
is by altering the crystal morphology from COM to COD. The latter has been shown 
to have a low binding affinity for renal epithelial cells, thus reducing crystal retention 
in the collecting duct (f=b,s no et a/ 1 :-.19:-J ;;;! e !:JI ... 0 ). This confirms the 
hypothesis that bikunin contributes to the ability of urine to inhibit in vivo 
crystallization. Literature has also indicated that bikunin alters the ratio of CaOx 
monohydrate (COM) to dihydrate crystallization (Wesson eta/. 1998). 
It needs to be noted that while SEM micrographs demonstrated an 
unfavourable crystal aggregate formation after addition of WB in BUF, addition of BB 
induced an inhibitory effect both in its native urine and in the cross-over experiment. 
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Furthermore the larger particles observed in the urine of the white subjects are 
consistent with the relatively higher stone occurrence in the South African white 
populations. This also confirms other findings in other experiments presented in 
other chapters. 
While these experiments showed the inhibitory capacity of bikunin, they were 
unable to differentiate between the proteins from the two race groups. As such the 
findings described in this chapter serve to support the protective role of bikunin in 
CaOx urolithiasis, but do not explain the difference in stone incidence in the two 
South African race groups. 
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Deglycosylation of bikunin and 
crystallization experiments in ultrafiltered 
urine from black and white subjects 
7.1 Introduction 
Glycosylation is a process whereby oligosaccharides are attached to proteins within 
the endoplasmic reticulum and Golgi apparatus of cells (Rudd and DweK 1997). 
Bikunin is a highly glycosylated protein (Koide et a/. 1981 ; Ebisuno 1999; 
Medetognon-Besissan et at. 1999; Yang eta/. 2005). It has two glycosylation sites, 
namely an 0-linked site whereby glycans are attached to a serine residue at position 
1 0 of the core protein linked via the chondroitin sulphate that contains 15 
disaccharide repeats, and an N-linked oligosaccharide at position 45 (Hochstrasse et 
a/. 1981 ). The 0-linked position is the more glycosylated of the two (Hochstrasser et 
at. 1981 ). The bikunin glycans account for approximately one third of the total 
molecular mass of the protein (Medetognon-Besissan et a/. 1999; Ebisuno et 
a/.1999; Yang eta/. 2005). 
Reports have indicated that bikunin's glycans are responsible for 70 - 90 % of 
its total inhibitory activity in urine (Koide et a/. 1981 ; Medetognon-Besissan et a/. 
1999). However these studies only report the effect of this protein in inorganic 
solutions and not in urine. Since it was established in Chapter 3 that commercial 
bikunin (CB) has inhibitory effect towards CaOx crystallization, the study presented 
in this chapter describes an investigation into the inhibitory effect of this bikunin after 
the removal of glycans. In addition, since studies in the present project have 
demonstrated that the urine milieu affects the functionality of bikunin, the 
crystallization experiments involving deglycosylated protein were conducted in 
ultrafiltered urine from both race groups wherever appropriate, to further explore this 
synergistic relationship. 
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Objectives 
• To deglycosylate bikunin using exoglycosylases 
• To study and compare the inhibitory effect of glycosylated and 
deglycosylated commercial bikunin on particle size, C4C]-oxalate 
deposition, crystal nucleation and aggregation as previously described in 
Chapter 3, 4 and 6, using ultrafiltered urine from both race groups where 
appropriate, to explore the synergistic relationship between functionality, 
structure and urine composition. 
• To study the inhibitory effects on CaOx crystal aggregation using an 
additional technique - zeta potential , which has not yet been utilized in the 
other studies of this thesis 
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7.2 Methods 
7 .2.1 Bikunin deglycosylation 
Enzymatic digestion 
Commercial bikunin (CB) was enzymatically deglycosylated using a method 
described by Capon et a/. (2003). Briefly, a control sample was prepared by 
incubating 400 1-1g CB in a 20 mM Gly/HCL pH 5.5, buffer containing 75 mM NaCI for 
16 hrs at 37 °C. To remove the 0-linked glycans, 400 1-Jg CB was treated similarly 
after addition of 16 1-JL of chondroitinase ABC (2.5 U/ml) (Sigma-Aldrich) which 
removes the 0-linked chondroitin sulphate chain. The solutions were then applied to 
a 10 kDa centricon membrane (Milipore) and centrifuged at 10 000 g for 11 min 
(Sorvall MC 12C centrifuge) to separate the released sugars and the partly 
deglycosylated protein. The sample protein on the membrane was then washed 
three times with 200 1-JL H20. To collect the partly deglycosylated protein, the 
membrane in the reservoir was inverted and centrifuged for -10 sec. 
Finally, to remove the N-linked glycans, the partly degycosylated protein was 
digested further using endoF2 (2.5 U/ml) and sialidase (2.5 U/ml) (Sigma-Aldrich). 
Clostridium perfringens sialidase (2.5 U/ml) (Sigma, Schnelldorf, Germany) removes 
a2-3, a2-6 and a2-8 linked sialic acids and Chryseobacterium (Flavobacterium) 
meningosepticum endoglycosidase F2 recombinant in E. coli (2.5 U/ml) (Sigma) 
cleaves between the two N-acetylglucosamine residues in the diacetylchitobiose 
core of the oligosaccharide. The remaining protein was then analyzed by MALDI-
TOF MS, Nano-Eiectrospray ionization mass spectrometry (Nano-ESI-MS) and 12 % 
SDS-PAGE in order to determine the glycosylation status of bikunin. Henceforth, the 
partially deglycosylated bikunin will be referred to as DB. 
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MALDI-TOF MS analysis 
1 1-Jg of protein (1 1-JL) was mixed with 1 1-JL MALDI-TOF MS matrix. The matrix was a 
saturated solution of 3,5-dimethoxy-4-hydroxycinnamic acid (Sinapinic acid) in 50 % 
acetonitrile and 0.3% TFA. The mixture (2 1-JL) was applied to a MALDI P100 gold 
sample plate and allowed to dry by gentle streaming with air to allow crystallization of 
the matrix and the sample. The sample was then analyzed using a Perseptive 
Biosystems Voyager DE-PRO Biospectrometry Workstation with Delayed Extraction 
Technology. 
Electron spray mass spectrometer 
Nano-Eiectrospray ionization mass spectrometry (Nano-ESI-MS) data was obtained 
using a quadrupole-time-of-flight (Q-TOF) (Ultima Global instrument, 
Waters/Micromass, Ltd, Manchester). Samples were prepared in 1:1 (v:v) 
methanol:water containing 1 % formic acid (Webber et at. 2006). 
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7 .2.2 Crystallization experiments 
Synthetic urine preparation 
Synthetic urine (SU) was prepared by mixing NaCI (320 mM); NaH2P04 (50 mM); 
MgCI2 (7.52 mM); KCI (164.2 mM); K3CsHs01.2H20 (4.34 mM); (NH4)2S04 (43.8 mM) 
and NH4CI (7.0 mM) in distilled water (Walton eta/. 2005). The pH was adjusted to 6 
using 5 M NaOH. To achieve a desired metastable limit, 50 mM Na20x and 120 mM 
CaCI2 were added to the filtered SU solution. 
Effect of CB and DB on {'4C]-oxalate deposition 
The effect of CB and DB on C4C]-oxalate deposition in SU, BUF and WUF was 
tested after dosing with each protein at a final concentration of 0.5 mg/L using the 
method described in Chapter 2.2.2, page 32. 
Effect of CB and DB on crystal aggregation 
A COM crystal slurry was prepared as described Chapter 2.2.2, page 35 and 
sedimentation rates were determined after the addition of protein as follows: 
COM+CB, COM+DB, COM+SU, COM+SU+CB, COM+SU+DB, COM+BUF, 
COM+BUF+CB, COM+BUF+DB, COM+WUF, COM+WUF+CB and COM+WUF+DB 
in the ratio of 1 :4 (Protein or urine: COM). 
Effect of CB and DB on crystal nucleation 
Separate solutions of 8.5 mM CaCI2 and 1 mM Na20x each containing 200 mM NaCI 
and 10 mM sodium acetate, pH 5.70 were prepared. The solutions were filtered 
(0.22 !Jm) before each experiment and the inhibitor was added to achieve a final 
concentration of 0.5 mg/L in the ratio of 2:1:2 (CaCb: Protein or urine: Na20x) as 
follows: C+CB, C+DB, C+SU, C+SU+CB, COM+SU+DB, C+BUF, C+BUF+CB, 
C+BUF+DB, C+WUF, C+WUF+CB and C+WUF+DB. 
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Effect of CB and DB on particle size distribution 
The urine was collected and pooled as described in Chapter 2.2.1, page 30. A 
Coulter Counter was used to determine the particle volume-size of SU, BUF and 
WUF before and after dosing with CB and DB at a final concentration of 0.5 mg/L 
using a method previously described in Chapter 2.2.2, page 37. SEM was used to 
view the crystals precipitated from the SU, BUF and WUF using a method described 
in Chapter 2.2.2, page 37. Three separate particle volume-size distribution 
measurements were made in SU. Five pooled urines from each race groups were 
collected for the particle volume-size distribution experiments. 
Effect of CB and DB on zeta potential 
Zeta potential, an indicator of the potential of a compound to reduce aggregation by 
action of its repulsive negative charge was measured using the method described by 
Hess eta/. (1989). COM crystals were prepared and characterized as described in 
Chapter 2.2.2, page 33. COM slurry (0.03 mg/ml), which was used as a control, was 
prepared by the addition of COM crystals to a 10 mM sodium acetate buffer, pH 5.7, 
containing 270 mM NaCI. The slurry was equilibrated overnight with constant stirring 
(11 00 rpm) at 25 °C. Thereafter, CB and DB were added at final concentrations of 
0.5 mg/L and equilibrated for a further 2 hrs. The zeta potential (mV) of the COM 
slurry before and after addition of CB and DB was measured using a Zetasizer 
Nanoseries (Malvern Instruments, England). Five independent experiments were 
conducted. 
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7.3 Results 
7 .3.1 Bikunin deglycosylation 
MALDI-TOF MS and Nano-ESI-MS 
Two peaks at 22920 and 15694 were observed in the undigested protein (Figure 
7.1). Treatment with chondroitinase ABC resulted in the reduction of the protein 
mass from 22920 to 18633 Da, a total mass loss of 4920 Da (Figure 7.2). The 
second peak at 16545 Da is almost similar to the 15694 Da signal before treatment 
with the enzyme. The protein mass after treatment with chondroitinase ABC, endoF2 
and sialidase was 14922 Da, which represent a total mass loss of 7889 Da. 
Figure 7.1: MALDI-TOF MS spectrum of CB 
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Figure 7.2: MALO I-TOF MS spectrum of CB after addition of chondroitinase ABC 
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Figure 7.3: MALDI-TOF MS spectrum of CB after addition of chondroitinase ABC, 
endoF2 and sialidase 
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SDS-PAGE 
In order to verify MALDI-TOF MS and Nano-ESI-MS results the digested proteins 
were analysed by 12 % SDS-PAGE. Figure 7.4 shows the gel of CB and the 
resulting products after enzyme digestion. The molecular masses of CB (lane 1) and 
that of the control sample in lane 2 incubated in buffer alone (lane 2) when run under 
reducing conditions were both 30 kDa. The mass of CB after treatment with 
chondroitinase ABC was 18 kDa under both reducing (lane 3) and non-reducing 
conditions (lane 3'). After treatment of CB with chondroitinase ABC, endoF2 and 
sialidase, three distinct bands were apparent at 15, 18 and 60 kDa under reducing 
(lane 4) and non-reducing conditions (lane 4'). 
Figure 7.4: SDS-PAGE of CB before and after enzyme digestion 
kDa M 1 2 3 3' 4 4' 
-
60 
40 I I 35 
20 I I 
15 
~---~~~------~----
Figure 7.4: 12% SDS-PAGE of CB (lane 1) and control (lane 
2) before treatment with chondroitinase ABC digestion (lane 3 
and 3') and treatment with chondroitinase ABC + endoF2 + 
sialidase (lane 4 and 4'). Lane M is the low molecular weight 
marker. 
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Comments: 
Enzyme treatment of CB was monitored by MALDI-TOF MS, Nano-ESI-MS and 
SDS-PAGE. According to MALDI-TOF MS, CB has a mass of 22920 Da. However, 
a band at 30 kDa was observed on 12% SDS-PAGE and this is consistent with the 
literature (Capon eta/. 2003). It is likely that the extensive glycosylation of bikunin 
affects its migration on the gel. MALO I-TOF MS also showed an additional mass of 
15694 Da suggesting the presence of a deglycosylated bikunin in the commercial 
bikunin preparation. However, this band was not observed on SDS-PAGE and this 
might be due to its low intensity. 
Removal of the chondroitin sulphate chain from bikunin by chondroitinase 
ABC reduced the glycosylated proteins' mass from 22920 to 18633 Da. The latter 
mass has been reported previously after digestion with chondroitinase ABC (!manari 
eta/. 1992; Capon eta/. 2003). The mass of bikunin treated with all three enzymes 
was 14930 Da, according to the MALDI-TOF MS which is the same as that predicted 
in the literature (lmanari et a!. 1992; Capon et a/. 2003; Yang et a/. 2005). 
Surprisingly, the protein after treatment with all three enzymes also showed two 
additional bands at 18 and 60 kDa on SDS-PAGE. The band at 18 kDa is likely due 
to incomplete deglycosylation after addition of endoF2 and sialidase and the other 
band at 60 kDa could not be accounted for. Thus only the commercial bikunin and 
ABC treated protein were used for further crystallization experiments. 
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7 .3.2 Crystallization experiments 
Synthetic urine experiments 
Effect of CB and DB on {'4C]-oxalate deposition 
In this experiment, CB and DB had a different effect after addition to SU, for example 
DB reduced the deposition of C4C]-oxalate to a lesser extent compared to CB. Figure 
7.5 shows the typical plot of C4C]-oxalate experiment before and after addition of CB 
and DB. The data and plots for each of the three experiments are shown in 
Appendix 4 (Table A4.1 and Figure A4.1 ). 
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Figure 7.7: A typical plot of percent precipitated C4C]-
oxalate of SU before and after addition of CB and DB at 
final concentrations of 0.5 mg/L 
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Comments: 
The speculation about the reduced inhibitory activity of CB after removal of glycans 
was confirmed by these results which showed that CaOx oxalate deposition 
inhibition by bikunin was greatly reduced after the removal of the glycans. This 
suggests that the CB's ability to inhibit CaOx crystal growth is largely due to the 
glycans. 
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Effect of SU, CB and DB on crystal aggregation 
Addition of CB and DB on COM crystal slurry significantly inhibited CaOx crystal 
aggregation. However, DB (range 58- 87 %, mean 74 %) reduced aggregation to a 
significantly lesser extent compared to CB (range 73-96 %, mean 87 %) as shown in 
Table 7.1 (p<0.05). A typical plot shown in Figure 7.6 demonstrates that the 
sedimentation rate was significantly reduced after addition of CB than when DB was 
added. The plots for each of these experiments are shown in Appendix 4 (Figure 
B4.1). 
Table 7.1: Absorbance slopes of COM crystal slurries before and after addition of 
CB and DB and inhibition of aggregation (% lA) 
Sample Absorbance slope 
(x10-5s-1) (R2) 
%lA 
COM (n=5) -520 (0.994) ± 31 .2 
COM+CB1 -40 (0.980) 92 
COM+CB2 -20 (0.978) 96 
COM+CB3 -60 (0.967) 88 
COM+CB4 -40 (0.987) 92 
COM+CB5 -110 (0.976) 79 
COM+CB6 -140 (0.976) 73 
Average -68 (0.978) ± 19.0 87 
COM+DB1 -190 (0.987) 63 
COM+DB2 -70 (0.982) 87 
COM+DB3 -90 (0.982) 83 
COM+DB4 -220 (0.951) 58 
COM+DB5 -90 (0.856) 83 
COM+DB6 -150 (0.967) 71 
Average -135 (0.954) ± 27.5 74 
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Figure 7.6: A typical plot of absorbance vs time plot of 
COM slurry before and after addition of CB and DB at final 
concentrations of 0.5 mg/L. The arrows indicate the time at 
which the stirring was stopped to induce aggregation 
The effect of CB and DB was also tested in the presence of SU. The results show 
that there was no apparent change when DB was added with SU (p>0.05). The 
percent inhibition after addition of SU increased significantly when CB (87%) was 
added. A typical plot for these experiments is shown in Figure 7.7. The data and 
plots for each experiment are shown in Appendix 4 (Table B4.1 and Figures B4.2). 
Table 7.2: Absorbance slopes and inhibition of aggregation(% lA) of COM crystal 
slurries before and after addition of SU, CB and DB 
Sample Absorbance slope %lA 
(x1 o·5s -1) (R2) 
520 0 994 , 
COM+SU (n=3, pools) -173 (0.983) 67 
COM+SU+CB (n=3, pools) -67 (0.961) 87 
COM+SU+DB (n=3, pools) -243 (0.975) 53 
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Figure 7.7: Typical absorbance vs time plot of COM 
slurry before and after addition of SU, CB and DB at 
final concentrations of 0.5 mg/L. 
Comments: 
These results indicate that both CB and DB have the ability to inhibit crystal 
aggregation when tested on their own, suggesting that aggregation inhibition by CB 
might not be entirely due to the CB glycans. However, DB's ability to inhibit CaOx 
crystal aggregation diminishes when SU is included in the mixture but a significant 
increase when CB was added. This is a further confirmation that bikunin glycans 
along with the nature of the synthetic urine are responsible for its ability bikunin to 
inhibit CaOx crystallization. 
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Effect of SU, CB and DB on crystal nucleation 
This experiment demonstrated that there were no significant differences between the 
effect of CB and DB. The percent inhibition of nucleation by CB (range 25-75 %, 
mean 46 %) and DB (25-50 % mean 45 %), was not significantly different (Table 
7.3). Figure 7.8 shows that nucleation was slightly delayed after addition both CB 
and DB. A typical plot for these experiments is illustrated in Figure 7.8 and plots for 
each experiment are shown in Appendix 4 (Figure C4.1 ). 
Table 7.3: Absorbance slopes and inhibition of nucleation (% In} before and after 
addition of CB and DB 
Sample Absorbance slope %In 
(x10"5s-1) (R2) ± SE 
Control (C) (n=5) 40 (0.951) ± 3.31 
C+CB1 30 (0.983) 25 
C+CB2 10 (0.983) 75 
C+CB3 30 (0.995) 25 
C+CB4 20 (0.987) 50 
C+CB5 20 (0.986) 50 
C+CB6 20 (0.981) 50 
Average 28 (0.986) ± 3.74 46 
C+DB1 20 (0.984) 50 
C+DB2 30 (0.991) 25 
C+DB3 20 (0.996) 50 
C+DB4 20 (0.996) 50 
C+DB5 20 (0.988) 50 
C+DB6 20 (0.982) 50 
Average 22 (0.990) + 1.67 45 
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Figure 7.8: A typical plot of absorbance vs time of the 
control before and after addition of BB and WB at a final 
concentration of 0.5 mg/L. 
The effect of CB and DB was also tested after inclusion of SU in the mixture. The 
highest inhibition was observed when only SU was tested (90 %, p<0.05). Addition 
of CB and DB did not increase the inhibition of nucleation indicating that the 
inhibition is largely due to the effect of SU. A typical plot for these experiments is 
shown Figure 7.9. The data presented in Table 7.4 shows the effect of CB and DB 
after addition SU. The data and plots for each experiment are shown in Appendix 4 
(Table C4.1 and Figure C4.2). 
Table 7.4: Absorbance slopes and percent inhibition of nucleation after addition of 
SU, CB and DB 
Sample Absorbance slope %In 
(x10-5s-1) (R2) 
0 0 95 
C+SU (n=3, pools) 4 (0.842) 90 
C+SU+CB (n=3, pools) 5 (0.956) 88 
C+SU+DB (n=3, pools) 5 (0.987) 88 
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Figure 7.9: A typical plot of absorbance vs time of the control 
before and after addition of SU, CB and DB 
Comments: 
The results from this experiment demonstrate that CaOx crystal nucleation was only 
inhibited when synthetic urine was tested on its own. Addition of CB or CB did not 
induce any change. This is an indication that CB and DB do not inhibit CaOx 
nucleation, thus confirming findings in Chapters 3 and 6. 
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Effect of CB and DB on particle size distribution 
A similar trend was observed in all three particle volume-size distribution 
experiments. As indicated by the distribution shift to the smaller size values in 
Figure 7.10, the particle size decreased significantly when CB was added to SU. A 
decrease observed when DB was added is not significant. Table 7.4 shows the 
particle size in SU before and after addition of CB and DB at a final concentration of 
0.5 mg/L. A typical plot of particle volume-size distribution in the SU before and after 
addition of CB and DB is shown in Figure 7.1 0. The plots for the each experiment 
are shown in Appendix 4; (CB: Figures D4.1; DB: Figures D4.2). 
Table 7.4: Modes of the particle size distribution (IJm) of the SU before and after 
addition of CB and DB 
Sample 
Experiment 1 
Experiment 2 
Experiment 3 
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Figure 7.10: Typical plot of particle volume-size distribution of 
SU before and after addition of CB and DB at a final 
concentration of 0.5 mg/L at 120 min. 
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Comments: 
A decrease in the particle size is an indication of growth inhibition. In all the 
experiments, addition of DB had reduced inhibitory effect compared to CB indicating 
that CB is a better particle growth inhibitor compared to DB. 
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SEM 
The SEM micrographs in Figure 7.11 show the CaOx crystals that were precipitated 
from SU. All the SEM micrographs before and after addition of CB were viewed at 
4K. SU had very few CaOx crystals and only COM crystal morphology was 
observed. The particle sizes appeared smaller in relation to SU after addition of CB 
(Figure 7.11 .2) and DB did not have an effect of the particle size (Figure 7.11.3). No 
apparent change was observed in the number of particles after addition of both CB 
and DB. 
Figure 7.11: SEM of SU before (Figure 7 .11.1) and after addition of CB (Figure 
7.11.2) and DB (Figure 7.11 .3) at final concentrations of 0.5 mg/L viewed at 4K 
Comments: 
SEM confirmed the observation in the particle size distribution experiment where it 
was demonstrated that size decreases more after addition of CB but when DB was 
added there was no apparent change. It is therefore concluded that CB glycans are 
responsible for the inhibition of crystal growth thus confirming reports in the literature 
(Koide et a/. 1981 ). 
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Ultrafiltered urine 
Effect of CB and DB on ( 4C]-oxalate deposition 
There was no apparent change in the CaOx oxalate deposition in BUF after addition 
of DB, however a decrease in [14C]-oxalate deposition was observed when CB was 
added. The CaOx oxalate deposited unfavourably increased upon addition of DB in 
WUF but decreased when CB was added. A typical plot depicting the inhibitory 
effect of CB and DB on the UF is shown below (Figure 7.12). The data and plots for 
each experiment are shown in Appendix 4 (Black subjects: Tables E4.1 and Figures 
F4.1; White subjects: Tables E4.2 and Figures F4.2). 
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Figure 7.12.1 
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Figure 7.12: C4C]- oxalate deposition of BUF (Figure: 7.12.1) 
and Figure 7.12.2) expressed as a percentage precipitated 
oxalate before and after addition of CB and DB 
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Comments: 
Addition of DB unfavourably promoted the deposition of CaOx deposition while CB 
significantly reduced the C4C]-oxalate deposited. This is an indication of CaOx 
crystal formation after the removal of glycans. 
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Effect of UF, CB and DB on crystal aggregation 
The inhibition of CaOx cystal aggregation by CB was 87 % and this percent inhibition 
increased when BUF (95 %) and WUF (92 %) were included in the mixture (Table 
7.5). The effect of DB was only 68% but this percent inhibition increased favourably 
when UF was included in the mixture irrespective of the race group from which it was 
derived. Figures 7.13 show a typical plot of the aggregation inhibition experiments. 
The rate of sedimentation is reduced more when CB is added to the COM crystal 
slurry as indicated by flattening of the slope after addition of CB. The data and plots 
for each of these experiments are presented in Appendix 4 (Black subjects: Tables 
F4.1 and Figures G4.1 , White subjects: Tables F4.2 and Figures G4.2). 
Table 7.5: Absorbance slopes and inhibition of aggregation (% lA) of COM crystal 
slurries before and after addition of CB and DB 
Sample Absorbance slope %lA 
(x10"5s"1) (R2) 
COM(n=5) -520 (0.994) 
COM+CB (n=5) -68 (0.978) 87 
COM+DB (n=5) -168 (0.954) 68 
COM+BUF (n=5) -164 (0.981) 69 
COM+BUF+CB {n=5) -28 (0.951) 95 
COM+BUF+DB (n=5) -128 (0.964) 75 
COM+WUF (n=5) -78 (0.976) 76 
COM+WUF+CB (n=5) · -44 (0.961) 92 
COM+WUF+DB (n=5) -150 (0.981) 71 
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Figure 7.13.1 
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Figure 7.13: A typical plot of absorbance vs time of COM slurry 
before and after addition of BUF (Figure 7.13.1 ), WUF (Figure 
7.13.2) , CB and DB at a final concentration of 0.5 mg/L. 
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Comment: 
The general principle that the urine milieu affects the inhibitory performance of 
bikunin was evident in the crystal aggregation experiment. The results demonstrate 
that the highest aggregation inhibition is achieved when CB is added with the urine. 
Addition of DB did not induce any change when tested with the urine. 
166 
C h a p t e r Seven 
Effect of UF, CB and DB on crystal nucleation 
Addition of DB to the control inhibited nucleation by only 13 % and the mean percent 
inhibition by CB was 46 %. The percent inhibition significantly increased upon 
addition of both BUF and WUF. The plot in Figure 7.14 show the mean plots of the 
nucleation experiment before and after addition of the inhibitor. The plot in Figure 
7.14 illustrate that nucleation is only delayed when UF is included in the reaction that 
CB and DB. Table 7.6 shows the mean data of the absorbance slope obtained from 
the plots presented in Appendix 4 (Black subjects: Tables G4.1 and Figure H4.1, 
White subjects: Tables G4.2 and Figure H4.2). 
Table 7.6: Absorbance slopes and inhibition of nucleation (% In) before and after 
addition of CB and DB 
Sample Absorbance slope (%In) 
(x1 0"5s "1) (R2) 
Control {C) (n=5) 40 (0.951) 
C+CB(n=5) 28 (0.986) 46 
C+DB_(n=5) 35 (0.990) 13 
C+BUF(n=5) 3.4 (0.967) 92 
C+BUF+CB (n=5) 7.0 (0.955) 83 
C+BUF+DB (n=5) 3.2 (0.928) 92 
C+WUF(n=5) 3.0 (0.947) 93 
C+WUF+CB (n=5) 2.4 (0.914) 94 
C+WUF+DB (n=5) 4.0 (0.933) 90 
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Figure 7.16: A typical plot of absorbance vs time of the control 
before and after addition of BUF (Figure 7.16.1), WUF (Figure 
7.16.2), CB and DB at a final concentration of 0.5 mg/L. 
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Comments: 
The results of these experiments have shown that the urine rather .than CB and DB 
inhibit CaOx crystal nucleation. The studies presented in other chapters have 
demonstrated that the urine milieu affects the functionality of the protein. However, 
the results obtained from the nucleation experiment in this study are disappointing, 
as there were no differences observed between BUF and WUF. 
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Effect of CB and DB on particle size distribution 
Surprisingly, an unfavourable increase in particle size was observed after addition of 
CB and DB in BUF in four experiments of five experiments. Addition of DB resulted 
in a greater particle size increase in BUF. The particle size distribution in WUF was 
bimodal and these experiments showed an insignificant decrease in the particle 
number when CB and DB were added. Table 7.7 shows the table of the particle size 
values obtained from the particle size distribution plots. A typical plot for these 
experiments is shown in Figure 7.15. These plots demonstrate a shift in the particle 
volume-size distribution to the larger values in BUF and a decrease in WUF after 
addition of CB and DB. The plots from which the particle sizes in Table 7.7 were 
derived are shown in Appendix 4 (Black subjects: B 4.1, White B 4.2). 
Table 7.7: Particle size (~m) of UF before and after addition of CB at a final 
concentration of 0.5 mg/L 
Sample 
Experiment 1 
Experiment 2** 
Experiment 3** 
Experiment 4 ** 
Experiment 5** 
Sample 
Experiment 1 * 
Experiment 2 
Experiment 3* 
Experiment 4* 
Experiment 5* 
**Trend showing an increase 
*Trend showing a decrease 
BUF 
4.0 
11.3 
10.6 
11.3 
8.7 
WUF 
12.4 and 17.1 
8.7 and 13.5 
19.3 and 24.4 
17.0 
12.8 and 17.8 
BUF+CB BUF+DB 
3.3 7.3 
17.0 24.2 
11.3 17.4 
14.6 13.1 
12.8 17.4 
WUF+CB WUF+DB 
10.9 and 14.6 11.3 and 14.9 
10.6 and14.6 10.2 and 13.0 
17.2 and 20.8 12.7 
14.4 12.4 
11 .3and15.7 11.7 and 14.9 
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Figure 7.15.1 
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Figure 7.15: Typical plot of particle size distribution of 
BUF (Figure 7.15.1) and WUF (Figure 7.15.2) subjects 
before and after addition of CB and DB. 
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Comments: 
Although the unfavourable increase in the particle size distribution is consistent with 
the reduced inhibitory activity of the deglycosylated protein, the results regarding the 
BUF experiment were surprising. For example, addition of CB in BUF resulted in a 
significant increase in the particle size indicating growth promotion. This observation 
is puzzling because it is inconsistent with the experiments in the previous chapters. 
However, the bimodal size distribution observed in the urine of white subjects is 
consistent and confirms a similar observation in other chapters. The general 
conclusion is that CB and DB do not significantly inhibit CaOx crystal growth. 
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SEM 
The SEM pictures of the CaOx crystals precipitated from the UF are shown in Figure 
7.16. The number of COD crystals observed in BUF decreased after addition of CB 
but the size greatly increased. An aggregate was also observed in BUF when DB 
was added. No apparent change in the particle number was observed after addition. 
The particle number and size decreased significantly in WUF when CB was added 
but the particle size appeared bigger when DB was added. 
Figure 7.16: Scanning electron micrographs of CaOx crystals precipitated 
from BUF (Figure 7.16.1) before and after addition of CB (Figure 7.16.2) and 
DB (Figure 7.16.3), and addition that ofWUF (Figure 7.16.4) before and after 
addition of CB (Figure 7.16.5) and after addition of DB (Figure 7.16.6) at a 
final concentration of 0.5 mg/L. 
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Comments: 
It was observed that addition of DB resulted in an increase in the particle size and 
this observation was confirmed by the SEM micrographs which also showed an 
unfavourable increase in particle size after addition of CB in BUF indicating 
promotion of particle growth. The particles appeared smaller when CB was added to 
WUF and DB did not significantly reduce the particle size as there were no apparent 
changes observed. 
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Effect of CB and DB on Zeta Potential 
Table 7.8 shows the zeta potential of the crystal slurry before and after addition of 
CB and DB. The average values are presented in Figure 7.17. The average zeta 
potential of the slurry before addition of CB and DB was -12.4 mV. The magnitude of 
the average negative charge of COM increased significantly to -16.6 mV after 
addition of CB (p=0.03) while there was no change after addition of DB (-12.7 mV, 
p=0.17). 
Table 7.8: Zeta potentials of COM slurry in the absence and presence of CB and DB 
COM (mV) 
-12.8 
-9.9 
-13.9 
-13.2 
-12.5 
-11.9 
Average: -12.4 ± 0.56 
> E 
-5 
::: -10 I'll 
;; 
c 
.s g_ -15 
~ 
N 
-20 
-25 
COM+CB (mV) 
-13.3 
-17.8 
-18.7 
-12.3 
-16.9 
-
-17.5±1.27 
Figure 7.17: Average zeta potential of crystal 
slurry in the presence and absence of CB and 
DB 
COM+DB (mV) 
-12.7 
-11.2 
-16.0 
-15.4 
-13.9 
-
-13.8 ± 0.88 
COM 
• COM+CB 
oCOM+DB 
175 
C h a p t e r Seven 
Comments 
Inhibition of crystal aggregation is related to changes in the surface charge that 
occur when an inhibitor such as bikunin binds to crystals and therefore the surface 
charge becoming more negative. A shift to a greater magnitude in the negative zeta 
potential is regarded as being favourable as it indicative of stronger repulsive forces 
which would retard aggregation. This shift, which may thus be attributed to inhibition 
of aggregation, was significantly more pronounced after addition of CB. The 
presence of CB in the COM slurry increased its negative charge which could mean 
that CB exerted stronger repulsive forces than DB and therefore indicating that CB is 
a superior inhibitor of crystal aggregation than DB. 
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7.4 Discussion 
Treatment of bikunin with chondroitinase has been reported to decrease the ability of 
bikunin to inhibit CaOx crystallization (Atmani et at. 1996; Yang eta/. 2005). In the 
present study CB's 0-linked glycans were successfully removed and deglycosylation 
with chondroitinase ABC resulted in the mass reduction of this protein from 22920 to 
18 000 Da. This is in agreement with literature values (Ebisuno et a/. 2003, Capon 
et a/. 2003; Yang et a/. 2005). The crystallization experiments on CB and 
deglycosylated bikunin (DB) were conducted in the synthetic urine and the 
ultrafiltered urine. 
Synthetic urine studies 
In order to test the inhibitory effect of CB and DB without any interference from other 
macromolecules that might be present in the urine, a neutral test solution was 
considered a necessity. Synthetic urine was prepared to mimic the urine and was 
used in these experiments for the first time as a neutral test solution. These 
experiments yielded results with a similar trend observed in all the experiments. The 
C4C)-oxalate deposition experiment along with the particle size distribution 
experiment demonstrated that CB inhibited crystal growth in the synthetic urine. 
These experiments also provided convincing evidence that commercial bikunin's 
inhibition of CaOx crystal formation reduces greatly after the removal of the glycans. 
It was also shown that DB inhibited CaOx crystal aggregation and nucleation to a 
lesser extent than CB. These observations are consistent with the reports which 
indicate that bikunin's glycans are responsible for 70 - 90 % of its inhibitory activity 
(Koide eta/. 1981; Medetognon-Besissan et at. 1999). 
Ultrafiltered urine studies 
As it was established in the synthetic urine that the inhibitory activity of CB reduces 
after the glycans have been removed, the same effect was also observed in the UF 
experiments. Since the study presented in this chapter was conducted to explore the 
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differences between the effect of CB and DB in the urine of black and white subjects, 
the findings in this chapter in this regard are disappointing. Because there no 
significant differences were observed between BUF and WUF in all the experiments, 
the results from this chapter are disappointing and inconsistent with the findings in 
Chapter 3. Growth inhibition is usually shown by a decrease in the amount of CaOx 
deposited and smaller particle sizes after addition of an inhibitor. These experiments 
along with the SEM demonstrate that CB and DB do not inhibit CaOx crystal growth. 
The bimodal size distribution and larger particle is consistent with findings in other 
chapters and this notion is discussed in detail in these chapters. Nucleation was 
only significantly inhibited by addition UF and therefore a comment cannot be made 
on the participation of glycans in this mechanism. 
In conclusion, the findings presented in this chapter suggest that chondroitin 
sulphate carbohydrate moiety of bikunin rather than the bikunin protein core are 
responsible for the inhibition of calcium oxalate crystallization. The findings in this 
study are in agreement with previous studies that have demonstrated that 
glycosaminoglycans such as chondroitin sulphate are inhibitor of CaOx growth and 
aggregation (Suzuki et at. 2001 ; Grases et at. 1991 ). 
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Chapter 8 
Conclusion and Future outlook 
8.1 Conclusion 
Since the effect of bikunin on CaOx crystallization in the urine of South Africa's 
population groups has not been previously undertaken, the objective for this PhD 
project was to isolate, characterize and extensively study the effect of this protein from 
the two race groups on CaOx crystallization with a view to gaining insights into why 
stone incidence is rare in the black population group. It is therefore appropriate to 
review the extent to which this objective was achieved. 
A study comparing the composition of the urine from black and white male subjects 
revealed a few significant differences and confirmed findings in other studies involving 
the two South African race groups (Chapter 2) . For example, urinary calcium was found 
to be 46 % lower in black subjects than in white subjects. Owing to the fact that 85 % of 
kidney stone is composed predominantly of calcium compounds (Ito et a/. 1992) these 
results suggest that differences in the composition of the urine may provide insight into 
the stone rarity in the South African black population. Since higher sodium has been 
reported to aggravate the development of kidney stone (Blacklock 1982; Robertson and 
Peackok 1983), it was surprising to observe that black subjects excreted less sodium 
compared to white subjects. The higher metastable limit observed in black subjects' 
urine demonstrates that the urine of black subjects can tolerate higher concentration of 
supersaturation without the formation of CaOx crystals. Although the urinary chemical 
composition and CaOx metastable limits results mentioned above are indeed related to 
the lower incidence, these parameters lie within the normal range and therefore they 
alone cannot account for the stone incidence differences observed in the two South 
African race groups. 
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As a lead-in to investigating the proposed objective, a series of crystallization studies 
were undertaken involving the commercially available bikunin. The crystallization 
experiments provided compelling evidence that commercial bikunin is an inhibitor of 
crystal aggregation, growth and nucleation. 
Different crystal matrices were precipitated from the urine to investigate the 
presence of bikunin for further purification. The presence of bikunin in COM, COD 
crystals and proteins precipitated using ammonium sulphate was confirmed in all these 
crystal matrix extracts using SDS-PAGE. However, Bradford assay demonstrated a 
higher total protein concentration in the proteins precipitated using ammonium sulphate. 
As such this method was used for further experiments and for bikunin isolation. The 
crystallization experiments were conducted on the protein precipitate containing bikunin. 
The results from these experiments demonstrated conclusively that proteins included in 
the precipitate (amongst which is bikunin), are potent inhibitors of CaOx growth, 
aggregation and nucleation crystallization, irrespective of the race groups and that these 
effects occurred in both the urine and inorganic solution. 
Bikunin itself was successfully isolated from the protein precipitated from the 
urine of black and white South African male subjects using immunoaffinity 
chromatography. The isolated protein was characterized with SDS-PAGE, Western 
blotting and MALDI-TOF MS. Although SDS-PAGE showed qualitative similarity 
between bikunin isolated from the urine of black and white subjects, MALDI-TOF MS 
showed a larger coverage of bikunin amino acids by bikunin isolated from black 
subjects. This suggests possible structural differences in the bikunin isolated from the 
urine of the two race groups. 
In addition to investigating the structural differences of bikunin isolated from the 
two race groups, the inhibitory activity of 88 and WB was compared using a series of 
crystallization experiments (Chapter 6) . These results revealed that bikunin was able to 
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retard CaOx crystallization irrespective of the race group from which it was derived. In 
particular bikunin was found to be a strong inhibitor of CaOx aggregation and growth 
rather than crystal nucleation. Nucleation has been reported to lower urinary 
supersaturation without producing particles of significant sizes, therefore it has been 
considered as a phenomenon of uncertain significance for stone formation (Coe et at. 
1991 , Hess eta/. 1995). However it is a vital precondition for further formation of larger 
particles within the urinary tract which ultimately might form a stone. Of further 
significance was the observation that bikunin alters the COM crystal morphology to 
COD. As it has been explained before, COD does not adhere to the epithelial cells. 
Thus, it appears as if bikunin is a major protective factor in kidney stone disease largely 
by altering the morphology from COM to COD (Chapter 6). 
Of great importance is that the results from this study provided key evidence in 
support of the original hypothesis of this thesis, namely that bikunin from the black 
subjects might play a major role in protecting this race group from kidney stone. This 
emerged from the observation that bikunin isolated from white subjects promoted crystal 
aggregation when added in the BUF, but the bikunin from the black subjects was able to 
retard CaOx crystallization, both in its native urine and in the cross-over experiment. 
Differences were for the first time observed when comparing the effect of 
commercial bikunin and isolated bikunin. For example, the particle size increased when 
CB was added to both BUF and WUF but a decrease was observed after addition of BB 
and WB. Also, a morphology change was observed after addition of BB and WB but 
that was not the case after addition of CB to UF. This suggests structural differences 
between these two different forms of bikunin. Further experiments are required to 
clarify the mechanism. 
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The contribution of the glycans, to the activity of bikunin was also investigated after 
enzymatic removal of chondroitin sulphate chains by comparing the inhibitory activity of 
this protein before and after removal of the glycans. In all the experiments, a decrease 
in inhibition was observed when the deglycosylated protein was added, demonstrating 
that bikunin deglycosylation reduces potency of the proteins inhibition of CaOx 
crystallization. Since several of these experiments were conducted in real urine for the 
first time, the results are extremely noteworthy. 
An interesting feature which was common in almost all the studies presented in 
this thesis regarding the differences between urine of black and white subjects was that 
white subjects have predominantly COD morphology while black subjects have 
predominantly COM morphology (Chapters 3, 6 and 7). This observation is not 
surprising since COD forms at higher calcium concentration and this supports the 
evidence that kidney stone disease is rare amongst the black South African population. 
Another interesting common feature is the larger particle size alon'g with the bimodal 
size distribution observed in the urine of the white subjects and not in blacks. It is 
reasonable to suggest that larger particles form due to reduced inhibition of crystal 
growth and aggregation. This also is consistent with the stone formation being 
prevalent in South African white population. 
Several experiments involving the different forms of bikunin demonstrated a 
synergistic dependence on the urine milieu. Furthermore, in some cases, the 
ultrafiltered urine from black subjects (BUF) had a more favourable effect than that of 
WUF. These effects were particularly apparent in the crystallization experiments 
involving commercial bikunin <C 4C]-oxalate deposition, sedimentation and Coulter 
experiments, page 72) and purified bikunin ([14C)-oxalate deposition and particle 
number, page 133) and are reported here for the first time. As has been discussed 
elsewhere in this thesis, similar synergistic relationship between protein functionality 
and urine composition have been reported for UPTF1, THP and Albumin. Of interest is 
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the absence of these effects in the study involving deglycosylated protein suggesting 
that bikunin glycans play a major role in the proteins' ability to inhibit CaOx 
crystallization. 
The differences in the urines of the two race groups coupled with crystallization 
experiment results from this thesis leads to the conclusion that bikunin may be a 
potential role-player in protecting the South African black population against CaOx 
lithogenesis. The importance of this protein in the pathogenesis of urolithiasis, can be 
attributable to the concentration, degree of glycosylation and its ability to alter the 
crystal morphology. 
8.2 Future Outlook 
Although this thesis provided more understanding on the remarkably low stone 
incidence in the South African black population, the role of this protein still warrants 
further studies in conjunction with other aspects, amongst these is diet. Studying the 
structure of bikunin and the effect of bikunin isolated from the urine of stone formers 
may also provide some more insight. 
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